0	0	1998-09-22	CD	O	O	B-Num
0	1	09	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	41	CD	O	O	I-Num
0	4	PROSTATE	NNP	O	O	B-Jour
0	5	CANCER	NNP	O	O	O
0	6	VICTIMS	NNS	O	O	O
0	7	FACE	NNP	O	O	O
0	8	CONFUSING	NNP	O	O	O
0	9	TREATMENT	NNP	O	O	O
0	10	OPTIONS	NNS	O	O	O

1	0	WASHINGTON	NNP	O	B-NP	B-LocStat
1	1	_	NN	O	I-NP	O
1	2	Prostate	NNP	O	I-NP	B-Jour
1	3	cancer	NN	O	I-NP	B-Medical
1	4	victims	NNS	O	I-NP	O
1	5	face	VBP	O	B-VP	O
1	6	a	DT	O	B-NP	O
1	7	confusing	JJ	O	I-NP	O
1	8	array	NN	O	I-NP	O
1	9	of	IN	O	B-PP	O
1	10	treatment	NN	O	B-NP	O
1	11	options	NNS	O	I-NP	O
1	12	COMMA	COMMA	O	O	O
1	13	all	DT	O	B-NP	O
1	14	carrying	VBG	O	B-VP	O
1	15	the	DT	O	B-NP	O
1	16	risk	NN	O	I-NP	O
1	17	of	IN	O	B-PP	O
1	18	such	JJ	O	B-NP	O
1	19	side	NN	O	I-NP	O
1	20	effects	NNS	O	I-NP	O
1	21	as	IN	O	B-PP	O
1	22	impotence	NN	O	B-NP	B-Medical
1	23	or	CC	O	O	O
1	24	incontinence	VB	O	B-VP	B-Medical
1	25	.	.	O	O	O

2	0	Patients	NNS	O	B-NP	O
2	1	complain	VBP	O	B-VP	O
2	2	that	IN	O	O	O
2	3	it	PRP	O	B-NP	O
2	4	's	VBZ	O	B-VP	O
2	5	often	RB	O	O	O
2	6	difficult	JJ	O	O	O
2	7	getting	VBG	O	B-VP	O
2	8	an	DT	O	B-NP	O
2	9	objective	NN	O	I-NP	O
2	10	recommendation	NN	O	I-NP	O
2	11	from	IN	O	B-PP	O
2	12	medical	JJ	O	B-NP	O
2	13	experts	NNS	O	I-NP	O
2	14	because	IN	O	O	O
2	15	each	DT	O	B-NP	O
2	16	physician	NN	O	I-NP	B-ProfTitle
2	17	tends	VBZ	O	O	O
2	18	to	TO	O	O	O
2	19	champion	NN	O	O	O
2	20	his	PP$	O	B-NP	O
2	21	or	CC	O	I-NP	O
2	22	her	PP$	O	I-NP	O
2	23	own	JJ	O	I-NP	O
2	24	speciality	NN	O	I-NP	O
2	25	.	.	O	O	O

3	0	A	DT	O	B-NP	O
3	1	urologist	NN	O	I-NP	O
3	2	might	MD	O	B-VP	O
3	3	urge	VB	O	I-VP	O
3	4	surgical	JJ	O	B-NP	B-Medical
3	5	removal	NN	O	I-NP	O
3	6	of	IN	O	B-PP	O
3	7	the	DT	O	B-NP	O
3	8	gland	NN	O	I-NP	O
3	9	;	:	O	O	O
3	10	a	DT	O	B-NP	O
3	11	radiologist	NN	O	I-NP	O
3	12	might	MD	O	B-VP	O
3	13	promote	VB	O	I-VP	O
3	14	radiation	NN	O	B-NP	O
3	15	or	CC	O	I-NP	O
3	16	radioactive	JJ	O	I-NP	O
3	17	``	``	O	I-NP	O
3	18	seed	NN	O	I-NP	O
3	19	''	''	O	I-NP	O
3	20	implants	NNS	O	I-NP	O
3	21	;	:	O	O	O
3	22	and	CC	O	O	O
3	23	an	DT	O	B-NP	O
3	24	oncologist	NN	O	I-NP	O
3	25	might	MD	O	B-VP	O
3	26	prefer	VB	O	I-VP	O
3	27	drugs	NNS	O	B-NP	O
3	28	to	TO	O	B-VP	O
3	29	shut	VB	O	I-VP	O
3	30	off	IN	O	B-PP	O
3	31	hormones	NNS	O	B-NP	B-Medical
3	32	feeding	VBG	O	B-VP	O
3	33	the	DT	O	B-NP	O
3	34	cancer	NN	O	I-NP	B-Medical
3	35	.	.	O	O	O

4	0	Choices	NNS	O	B-NP	O
4	1	are	VBP	O	B-VP	O
4	2	becoming	VBG	O	I-VP	O
4	3	even	RB	O	O	O
4	4	more	RBR	O	O	O
4	5	complex	NN	O	O	O
4	6	as	IN	O	O	O
4	7	doctors	NNS	O	B-NP	B-ProfTitle
4	8	refine	VB	O	B-VP	O
4	9	new	JJ	O	B-NP	O
4	10	treatments	NNS	O	I-NP	O
4	11	such	JJ	O	B-PP	O
4	12	as	IN	O	I-PP	O
4	13	cryosurgery	NN	O	B-NP	O
4	14	-LBR-	-LBR-	O	I-NP	O
4	15	freezing	VBG	O	I-NP	O
4	16	of	IN	O	B-PP	O
4	17	the	DT	O	B-NP	O
4	18	prostate	NN	O	I-NP	B-Jour
4	19	gland	NN	O	I-NP	O
4	20	-RBR-	-RBR-	O	I-NP	O
4	21	and	CC	O	I-NP	O
4	22	various	JJ	O	I-NP	O
4	23	combinations	NNS	O	I-NP	O
4	24	of	IN	O	B-PP	O
4	25	treatments	NNS	O	B-NP	O
4	26	.	.	O	O	O

5	0	Medical	NNP	O	B-NP	B-OrgCorp
5	1	practioners	NNS	O	I-NP	O
5	2	are	VBP	O	B-VP	O
5	3	trying	VBG	O	I-VP	O
5	4	to	TO	O	I-VP	O
5	5	determine	VB	O	I-VP	O
5	6	which	WDT	O	B-NP	O
5	7	treatment	NN	O	I-NP	O
5	8	is	VBZ	O	B-VP	O
5	9	best	JJS	O	O	O
5	10	COMMA	COMMA	O	O	O
5	11	but	CC	O	O	O
5	12	each	DT	O	B-NP	O
5	13	new	JJ	O	I-NP	O
5	14	medical	JJ	O	I-NP	O
5	15	study	NN	O	I-NP	O
5	16	seems	VBZ	O	B-VP	O
5	17	to	TO	O	I-VP	O
5	18	raise	VB	O	I-VP	O
5	19	more	JJR	O	B-NP	O
5	20	questions	NNS	O	I-NP	O
5	21	.	.	O	O	O

6	0	Most	RBS	O	O	B-Peop
6	1	recently	RB	O	O	O
6	2	COMMA	COMMA	O	O	O
6	3	a	DT	O	B-NP	O
6	4	study	NN	O	I-NP	O
6	5	published	VBD	O	B-VP	O
6	6	this	DT	O	B-NP	O
6	7	month	NN	O	I-NP	O
6	8	in	IN	O	B-PP	O
6	9	the	DT	O	B-NP	O
6	10	Journal	NNP	O	I-NP	B-Jour
6	11	of	IN	O	B-PP	O
6	12	the	DT	O	B-NP	O
6	13	American	NNP	O	I-NP	B-OrgCorp
6	14	Medical	NNP	O	I-NP	I-OrgCorp
6	15	Association	NNP	O	I-NP	I-OrgCorp
6	16	found	VBD	O	B-VP	O
6	17	that	IN	O	O	O
6	18	patients	NNS	O	B-NP	O
6	19	with	IN	O	B-PP	O
6	20	fast-moving	JJ	O	B-NP	O
6	21	prostate	NN	O	I-NP	B-Jour
6	22	cancer	NN	O	I-NP	B-Medical
6	23	lived	VBD	O	B-VP	O
6	24	longer	RB	O	O	O
6	25	when	WRB	O	O	O
6	26	treated	VBN	O	B-VP	O
6	27	with	IN	O	B-PP	O
6	28	either	DT	O	B-NP	O
6	29	surgery	NN	O	I-NP	O
6	30	or	CC	O	I-NP	O
6	31	traditional	JJ	O	I-NP	O
6	32	radiation	NN	O	I-NP	O
6	33	COMMA	COMMA	O	O	O
6	34	rather	RB	O	O	O
6	35	than	IN	O	O	O
6	36	seed	NN	O	B-NP	O
6	37	implants	NNS	O	I-NP	O
6	38	_	NN	O	I-NP	O
6	39	an	DT	O	B-NP	O
6	40	increasingly	RB	O	I-NP	O
6	41	popular	JJ	O	I-NP	O
6	42	treatment	NN	O	I-NP	O
6	43	.	.	O	O	O

7	0	The	DT	O	B-NP	O
7	1	same	JJ	O	I-NP	O
7	2	study	NN	O	I-NP	O
7	3	found	VBD	O	B-VP	O
7	4	that	IN	O	O	O
7	5	men	NNS	O	B-NP	O
7	6	with	IN	O	B-PP	O
7	7	early-stage	JJ	O	B-NP	O
7	8	cancer	NN	O	I-NP	B-Medical
7	9	fared	VBD	O	B-VP	O
7	10	well	RB	O	O	O
7	11	regardless	RB	O	O	O
7	12	of	IN	O	B-PP	O
7	13	which	WDT	O	B-NP	O
7	14	treatment	NN	O	I-NP	O
7	15	they	PRP	O	B-NP	O
7	16	received	VBD	O	B-VP	O
7	17	.	.	O	O	O

8	0	``	``	O	O	O
8	1	A	DT	O	B-NP	O
8	2	lot	NN	O	I-NP	O
8	3	of	IN	O	B-PP	O
8	4	the	DT	O	B-NP	O
8	5	information	NN	O	I-NP	O
8	6	out	IN	O	O	O
8	7	there	EX	O	B-NP	O
8	8	is	VBZ	O	B-VP	O
8	9	very	RB	O	O	O
8	10	confusingCOMMA	NN	O	O	O
8	11	''	''	O	O	O
8	12	said	VBD	O	B-VP	O
8	13	Derek	NNP	O	B-NP	B-Peop
8	14	Durst	NNP	O	I-NP	I-Peop
8	15	COMMA	COMMA	O	O	O
8	16	a	DT	O	B-NP	O
8	17	50-year-old	JJ	O	I-NP	B-Num
8	18	real	JJ	O	I-NP	O
8	19	estate	NN	O	I-NP	O
8	20	agent	NN	O	I-NP	B-ProfTitle
8	21	and	CC	O	I-NP	O
8	22	teacher	NN	O	I-NP	B-ProfTitle
8	23	from	IN	O	B-PP	O
8	24	San	NNP	O	B-NP	B-LocCit
8	25	Francisco	NNP	O	I-NP	I-LocCit
8	26	COMMA	COMMA	O	O	O
8	27	who	WP	O	B-NP	O
8	28	was	VBD	O	B-VP	O
8	29	diagnosed	VBN	O	I-VP	O
8	30	with	IN	O	B-PP	O
8	31	prostate	NN	O	B-NP	B-Jour
8	32	cancer	NN	O	I-NP	B-Medical
8	33	in	IN	O	B-PP	O
8	34	February	NNP	O	B-NP	B-Date
8	35	.	.	O	O	O

9	0	Durst	NNP	O	B-NP	B-Peop
9	1	wants	VBZ	O	B-VP	O
9	2	to	TO	O	I-VP	O
9	3	avoid	VB	O	I-VP	O
9	4	surgical	JJ	O	B-NP	B-Medical
9	5	removal	NN	O	I-NP	O
9	6	of	IN	O	B-PP	O
9	7	his	PP$	O	B-NP	O
9	8	prostate	NN	O	I-NP	B-Jour
9	9	_	NN	O	I-NP	O
9	10	a	DT	O	B-NP	O
9	11	radical	JJ	O	I-NP	O
9	12	prostatectomy	NN	O	I-NP	O
9	13	_	NN	O	I-NP	O
9	14	but	CC	O	O	O
9	15	he	PRP	O	B-NP	O
9	16	's	VBZ	O	B-VP	O
9	17	uncertain	JJ	O	O	O
9	18	whether	IN	O	O	O
9	19	to	TO	O	B-VP	O
9	20	select	VB	O	I-VP	O
9	21	radioactive	JJ	O	B-NP	O
9	22	seed	NN	O	I-NP	O
9	23	implants	NNS	O	I-NP	O
9	24	or	CC	O	O	O
9	25	several	JJ	O	B-NP	O
9	26	treatments	NNS	O	I-NP	O
9	27	in	IN	O	B-PP	O
9	28	sequence	NN	O	B-NP	O
9	29	.	.	O	O	O

10	0	``	``	O	O	O
10	1	Should	MD	O	O	O
10	2	I	PRP	O	B-NP	O
10	3	do	VB	O	B-VP	O
10	4	a	DT	O	B-NP	O
10	5	combination	NN	O	I-NP	B-Medical
10	6	of	IN	O	B-PP	O
10	7	hormonal	JJ	O	B-NP	B-Medical
10	8	blockade	NN	O	I-NP	O
10	9	COMMA	COMMA	O	O	O
10	10	then	RB	O	O	O
10	11	seeds	NNS	O	B-NP	O
10	12	and	CC	O	O	O
10	13	then	RB	O	O	O
10	14	radiation	NN	O	B-NP	O
10	15	?	.	O	O	O
10	16	''	''	O	O	O
10	17	he	PRP	O	B-NP	O
10	18	wonders	VBZ	O	B-VP	O
10	19	.	.	O	O	O

11	0	``	``	O	O	O
11	1	It	PRP	O	B-NP	O
11	2	's	VBZ	O	B-VP	O
11	3	very	RB	O	O	O
11	4	difficult	JJ	O	O	O
11	5	to	TO	O	B-VP	O
11	6	make	VB	O	I-VP	O
11	7	a	DT	O	B-NP	O
11	8	choice	NN	O	I-NP	O
11	9	.	.	O	O	O

12	0	You	PRP	O	B-NP	O
12	1	have	VBP	O	B-VP	O
12	2	to	TO	O	I-VP	O
12	3	become	VB	O	I-VP	O
12	4	your	PP$	O	B-NP	O
12	5	own	JJ	O	I-NP	O
12	6	case	NN	O	I-NP	O
12	7	manager	NN	O	I-NP	B-ProfTitle
12	8	.	.	O	O	O
12	9	''	''	O	O	O

13	0	David	NNP	O	B-NP	B-Peop
13	1	Evans	NNP	O	I-NP	I-Peop
13	2	COMMA	COMMA	O	O	O
13	3	a	DT	O	B-NP	O
13	4	retired	VBN	O	I-NP	O
13	5	diplomat	NN	O	I-NP	O
13	6	in	IN	O	B-PP	O
13	7	Washington	NNP	O	B-NP	B-LocCit
13	8	COMMA	COMMA	O	O	O
13	9	D.C.	NNP	O	B-NP	B-LocStat
13	10	COMMA	COMMA	O	O	O
13	11	said	VBD	O	B-VP	O
13	12	that	IN	O	O	O
13	13	soon	RB	O	O	O
13	14	after	IN	O	O	O
13	15	he	PRP	O	B-NP	O
13	16	was	VBD	O	B-VP	O
13	17	diagnosed	VBN	O	I-VP	O
13	18	in	IN	O	B-PP	O
13	19	1992	CD	O	B-NP	B-Date
13	20	at	IN	O	B-PP	O
13	21	age	NN	O	B-NP	O
13	22	56	CD	O	I-NP	B-Num
13	23	COMMA	COMMA	O	O	O
13	24	``	``	O	O	O
13	25	I	PRP	O	B-NP	O
13	26	quickly	RB	O	B-VP	O
13	27	found	VBD	O	I-VP	O
13	28	out	IN	O	O	O
13	29	that	IN	O	O	O
13	30	in	IN	O	B-PP	O
13	31	prostate	NN	O	B-NP	B-Jour
13	32	cancer	NN	O	I-NP	B-Medical
13	33	the	DT	O	B-NP	O
13	34	patient	NN	O	I-NP	B-Medical
13	35	bears	VBZ	O	B-VP	O
13	36	an	DT	O	B-NP	O
13	37	overwhelming	JJ	O	I-NP	O
13	38	responsibility	NN	O	I-NP	O
13	39	for	IN	O	B-PP	O
13	40	deciding	VBG	O	B-VP	O
13	41	on	IN	O	B-PP	O
13	42	his	PP$	O	B-NP	O
13	43	treatment	NN	O	I-NP	O
13	44	.	.	O	O	O
13	45	''	''	O	O	O

14	0	Dr.	NNP	O	B-NP	B-ProfTitle
14	1	Marc	NNP	O	I-NP	B-Peop
14	2	Garnick	NNP	O	I-NP	I-Peop
14	3	COMMA	COMMA	O	O	O
14	4	an	DT	O	B-NP	O
14	5	oncologist	NN	O	I-NP	O
14	6	and	CC	O	I-NP	O
14	7	internist	NN	O	I-NP	O
14	8	on	IN	O	B-PP	O
14	9	the	DT	O	B-NP	O
14	10	faculty	NN	O	I-NP	O
14	11	at	IN	O	B-PP	O
14	12	the	DT	O	B-NP	O
14	13	Harvard	NNP	O	I-NP	B-OrgCorp
14	14	Medical	NNP	O	I-NP	I-OrgCorp
14	15	School	NNP	O	I-NP	I-OrgCorp
14	16	COMMA	COMMA	O	O	O
14	17	said	VBD	O	B-VP	O
14	18	some	DT	O	B-NP	O
14	19	cases	NNS	O	I-NP	O
14	20	are	VBP	O	B-VP	O
14	21	``	``	O	O	O
14	22	absolutely	RB	O	O	O
14	23	black	JJ	O	O	B-Color
14	24	and	CC	O	O	O
14	25	white	JJ	O	O	B-Color
14	26	about	IN	O	B-PP	O
14	27	what	WP	O	B-NP	O
14	28	needs	VBZ	O	B-VP	O
14	29	to	TO	O	I-VP	O
14	30	get	VB	O	I-VP	O
14	31	done	VBN	O	I-VP	O
14	32	.	.	O	O	O

15	0	The	DT	O	B-NP	O
15	1	rest	NN	O	I-NP	O
15	2	of	IN	O	B-PP	O
15	3	the	DT	O	B-NP	O
15	4	patients	NNS	O	I-NP	O
15	5	fit	VBP	O	B-VP	O
15	6	into	IN	O	B-PP	O
15	7	the	DT	O	B-NP	O
15	8	bulk	NN	O	I-NP	O
15	9	of	IN	O	B-PP	O
15	10	the	DT	O	B-NP	O
15	11	bell-shaped	JJ	O	I-NP	O
15	12	curve	NN	O	I-NP	B-Medical
15	13	where	WRB	O	O	O
15	14	any	DT	O	B-NP	O
15	15	one	CD	O	I-NP	B-Num
15	16	of	IN	O	B-PP	O
15	17	a	DT	O	B-NP	O
15	18	variety	NN	O	I-NP	O
15	19	of	IN	O	B-PP	O
15	20	treatment	NN	O	B-NP	O
15	21	options	NNS	O	I-NP	O
15	22	is	VBZ	O	B-VP	O
15	23	appropriate	JJ	O	O	O
15	24	.	.	O	O	O
15	25	''	''	O	O	O

16	0	Dr.	NNP	O	B-NP	B-ProfTitle
16	1	William	NNP	O	I-NP	B-Peop
16	2	Shipley	NNP	O	I-NP	I-Peop
16	3	COMMA	COMMA	O	O	O
16	4	the	DT	O	B-NP	O
16	5	head	NN	O	I-NP	O
16	6	of	IN	O	B-PP	O
16	7	genito-urinary	JJ	O	B-NP	O
16	8	radiation	NN	O	I-NP	O
16	9	oncology	NN	O	I-NP	B-Jour
16	10	at	IN	O	B-PP	O
16	11	the	DT	O	B-NP	O
16	12	Massachusetts	NNP	O	I-NP	B-LocStat
16	13	General	NNP	O	I-NP	B-ProfTitle
16	14	Hospital	NNP	O	I-NP	O
16	15	in	IN	O	B-PP	O
16	16	Boston	NNP	O	B-NP	B-LocCit
16	17	COMMA	COMMA	O	O	O
16	18	advises	VBZ	O	B-VP	O
16	19	patients	NNS	O	B-NP	O
16	20	to	TO	O	B-VP	O
16	21	interview	VB	O	I-VP	O
16	22	experienced	VBD	O	I-VP	O
16	23	physicians	NNS	O	B-NP	B-ProfTitle
16	24	and	CC	O	O	O
16	25	learn	VB	O	B-VP	O
16	26	all	DT	O	B-NP	O
16	27	they	PRP	O	B-NP	O
16	28	can	MD	O	B-VP	O
16	29	about	IN	O	B-PP	O
16	30	the	DT	O	B-NP	O
16	31	disease	NN	O	I-NP	B-Medical
16	32	and	CC	O	O	O
16	33	its	PP$	O	B-NP	O
16	34	treatments	NNS	O	I-NP	O
16	35	.	.	O	O	O

17	0	``	``	O	O	O
17	1	Men	NNS	O	B-NP	O
17	2	should	MD	O	B-VP	O
17	3	hear	VB	O	I-VP	O
17	4	various	JJ	O	B-NP	O
17	5	points	NNS	O	I-NP	O
17	6	of	IN	O	B-PP	O
17	7	view	VBP	O	B-NP	O
17	8	from	IN	O	B-PP	O
17	9	credible	JJ	O	B-NP	O
17	10	sources	NNS	O	I-NP	O
17	11	COMMA	COMMA	O	O	O
17	12	particularly	RB	O	O	O
17	13	about	IN	O	B-PP	O
17	14	the	DT	O	B-NP	O
17	15	side	NN	O	I-NP	O
17	16	effects	NNS	O	I-NP	O
17	17	COMMA	COMMA	O	O	O
17	18	and	CC	O	O	O
17	19	get	VBP	O	B-VP	O
17	20	a	DT	O	B-NP	O
17	21	fair	JJ	O	I-NP	O
17	22	story	NN	O	I-NP	O
17	23	of	IN	O	B-PP	O
17	24	the	DT	O	B-NP	O
17	25	success	NN	O	I-NP	O
17	26	rates	NNS	O	I-NP	O
17	27	and	CC	O	O	O
17	28	then	RB	O	B-VP	O
17	29	select	VBP	O	I-VP	O
17	30	what	WP	O	B-NP	O
17	31	suits	VBZ	O	B-VP	O
17	32	them	PRP	O	B-NP	O
17	33	bestCOMMA	NN	O	B-NP	O
17	34	''	''	O	O	O
17	35	Shipley	NNP	O	B-NP	B-Peop
17	36	said	VBD	O	B-VP	O
17	37	.	.	O	O	O

18	0	The	DT	O	B-NP	O
18	1	bed-rock	JJ	O	I-NP	O
18	2	principles	NNS	O	I-NP	O
18	3	guiding	VBG	O	O	O
18	4	physicians	NNS	O	B-NP	B-ProfTitle
18	5	and	CC	O	I-NP	O
18	6	patients	NNS	O	I-NP	O
18	7	are	VBP	O	B-VP	O
18	8	that	IN	O	O	O
18	9	a	DT	O	B-NP	O
18	10	man	NN	O	I-NP	O
18	11	can	MD	O	B-VP	O
18	12	be	VB	O	I-VP	O
18	13	cured	VBN	O	I-VP	O
18	14	if	IN	O	O	O
18	15	the	DT	O	B-NP	O
18	16	disease	NN	O	I-NP	B-Medical
18	17	is	VBZ	O	B-VP	O
18	18	caught	VBN	O	I-VP	O
18	19	early	RB	O	O	O
18	20	and	CC	O	O	O
18	21	is	VBZ	O	B-VP	O
18	22	confined	VBN	O	I-VP	O
18	23	to	TO	O	B-PP	O
18	24	the	DT	O	B-NP	O
18	25	prostate	NN	O	I-NP	B-Jour
18	26	;	:	O	O	O
18	27	if	IN	O	O	O
18	28	not	RB	O	O	O
18	29	COMMA	COMMA	O	O	O
18	30	a	DT	O	B-NP	O
18	31	cure	NN	O	I-NP	O
18	32	is	VBZ	O	B-VP	O
18	33	less	RBR	O	O	O
18	34	likely	JJ	O	O	O
18	35	COMMA	COMMA	O	O	O
18	36	though	IN	O	O	O
18	37	the	DT	O	B-NP	O
18	38	disease	NN	O	I-NP	B-Medical
18	39	may	MD	O	B-VP	O
18	40	be	VB	O	I-VP	O
18	41	kept	VBN	O	I-VP	O
18	42	at	IN	O	B-PP	O
18	43	bay	NN	O	B-NP	O
18	44	for	IN	O	B-PP	O
18	45	several	JJ	O	B-NP	O
18	46	years	NNS	O	I-NP	B-Date
18	47	.	.	O	O	O

19	0	For	IN	O	B-PP	O
19	1	many	JJ	O	B-NP	O
19	2	older	JJR	O	I-NP	O
19	3	men	NNS	O	I-NP	O
19	4	COMMA	COMMA	O	O	O
19	5	a	DT	O	B-NP	O
19	6	cure	NN	O	I-NP	O
19	7	may	MD	O	B-VP	O
19	8	not	RB	O	I-VP	O
19	9	be	VB	O	I-VP	O
19	10	necessary	JJ	O	O	O
19	11	because	IN	O	O	O
19	12	they	PRP	O	B-NP	O
19	13	will	MD	O	B-VP	O
19	14	die	VB	O	I-VP	O
19	15	of	IN	O	B-PP	O
19	16	other	JJ	O	B-NP	O
19	17	causes	NNS	O	I-NP	O
19	18	before	IN	O	B-PP	O
19	19	the	DT	O	B-NP	O
19	20	prostate	NN	O	I-NP	B-Jour
19	21	cancer	NN	O	I-NP	B-Medical
19	22	turns	VBZ	O	B-VP	O
19	23	lethal	JJ	O	O	B-Medical
19	24	.	.	O	O	O

20	0	``	``	O	O	O
20	1	That	DT	O	B-NP	O
20	2	's	VBZ	O	B-VP	O
20	3	what	WP	O	B-NP	O
20	4	makes	VBZ	O	B-VP	O
20	5	it	PRP	O	B-NP	O
20	6	complicatedCOMMA	NN	O	B-NP	O
20	7	''	''	O	O	O
20	8	said	VBD	O	B-VP	O
20	9	Dr.	NNP	O	B-NP	B-ProfTitle
20	10	Howard	NNP	O	I-NP	B-Peop
20	11	Scher	NNP	O	I-NP	I-Peop
20	12	COMMA	COMMA	O	O	O
20	13	chief	NN	O	B-NP	B-ProfTitle
20	14	of	IN	O	B-PP	O
20	15	genito-urinary	JJ	O	B-NP	O
20	16	oncology	NN	O	I-NP	B-Jour
20	17	at	IN	O	B-PP	O
20	18	the	DT	O	B-NP	O
20	19	Memorial	NNP	O	I-NP	O
20	20	Sloan-Kettering	NNP	O	I-NP	O
20	21	Cancer	NNP	O	I-NP	O
20	22	Center	NNP	O	I-NP	O
20	23	in	IN	O	B-PP	O
20	24	New	NNP	O	B-NP	B-LocCit
20	25	York	NNP	O	I-NP	I-LocCit
20	26	.	.	O	O	O

21	0	``	``	O	O	O
21	1	The	DT	O	B-NP	O
21	2	major	JJ	O	I-NP	O
21	3	issue	NN	O	I-NP	O
21	4	is	VBZ	O	B-VP	O
21	5	to	TO	O	B-VP	O
21	6	determine	VB	O	I-VP	O
21	7	what	WP	O	B-NP	O
21	8	the	DT	O	B-NP	O
21	9	risk	NN	O	I-NP	O
21	10	of	IN	O	B-PP	O
21	11	the	DT	O	B-NP	O
21	12	disease	NN	O	I-NP	B-Medical
21	13	is	VBZ	O	B-VP	O
21	14	for	IN	O	B-PP	O
21	15	the	DT	O	B-NP	O
21	16	individual	JJ	O	I-NP	O
21	17	patient	NN	O	I-NP	B-Medical
21	18	.	.	O	O	O
21	19	''	''	O	O	O

22	0	``	``	O	O	O
22	1	Cure	NNP	O	B-NP	O
22	2	''	''	O	O	O
22	3	is	VBZ	O	B-VP	O
22	4	a	DT	O	B-NP	O
22	5	word	NN	O	I-NP	O
22	6	prostate	NN	O	I-NP	B-Jour
22	7	specialists	NNS	O	I-NP	B-ProfTitle
22	8	use	VBP	O	B-VP	O
22	9	cautiously	RB	O	O	O
22	10	.	.	O	O	O

23	0	Some	DT	O	B-NP	O
23	1	contend	VBP	O	B-VP	O
23	2	that	IN	O	O	O
23	3	a	DT	O	B-NP	O
23	4	successful	JJ	O	I-NP	O
23	5	treatment	NN	O	I-NP	O
23	6	strategy	NN	O	I-NP	O
23	7	is	VBZ	O	B-VP	O
23	8	to	TO	O	B-VP	O
23	9	keep	VB	O	I-VP	O
23	10	the	DT	O	B-NP	O
23	11	cancer	NN	O	I-NP	B-Medical
23	12	under	IN	O	B-PP	O
23	13	control	NN	O	B-NP	O
23	14	for	IN	O	B-PP	O
23	15	long	JJ	O	B-NP	O
23	16	periods	NNS	O	I-NP	O
23	17	.	.	O	O	O

24	0	In	IN	O	B-PP	O
24	1	other	JJ	O	B-NP	O
24	2	words	NNS	O	I-NP	O
24	3	COMMA	COMMA	O	O	O
24	4	to	TO	O	B-VP	O
24	5	manage	VB	O	I-VP	O
24	6	it	PRP	O	B-NP	O
24	7	like	IN	O	B-PP	O
24	8	a	DT	O	B-NP	O
24	9	chronic	JJ	O	I-NP	B-Medical
24	10	illness	NN	O	I-NP	O
24	11	.	.	O	O	O

25	0	``	``	O	O	O
25	1	There	EX	O	B-NP	O
25	2	are	VBP	O	B-VP	O
25	3	two	CD	O	B-NP	B-Num
25	4	clocks	NNS	O	I-NP	O
25	5	ticking	VBG	O	O	O
25	6	:	:	O	O	O
25	7	your	PP$	O	O	O
25	8	prostate	NN	O	B-NP	B-Jour
25	9	clock	NN	O	I-NP	O
25	10	and	CC	O	O	O
25	11	your	PP$	O	B-NP	O
25	12	life	NN	O	I-NP	O
25	13	clockCOMMA	NN	O	I-NP	O
25	14	''	''	O	O	O
25	15	said	VBD	O	B-VP	O
25	16	Dr.	NNP	O	B-NP	B-ProfTitle
25	17	Alan	NNP	O	I-NP	B-Peop
25	18	Partin	NNP	O	I-NP	I-Peop
25	19	COMMA	COMMA	O	O	O
25	20	a	DT	O	B-NP	O
25	21	urologist	NN	O	I-NP	O
25	22	at	IN	O	B-PP	O
25	23	Johns	NNP	O	B-NP	B-OrgUniv
25	24	Hopkins	NNP	O	I-NP	I-OrgUniv
25	25	University	NNP	O	I-NP	I-OrgUniv
25	26	in	IN	O	B-PP	O
25	27	Baltimore	NNP	O	B-NP	B-LocCit
25	28	.	.	O	O	O

26	0	``	``	O	O	O
26	1	If	IN	O	O	O
26	2	I	PRP	O	B-NP	O
26	3	can	MD	O	B-VP	O
26	4	keep	VB	O	I-VP	O
26	5	your	PP$	O	O	O
26	6	prostate	NN	O	B-NP	B-Jour
26	7	clock	NN	O	I-NP	O
26	8	just	RB	O	O	O
26	9	behind	IN	O	B-PP	O
26	10	your	PP$	O	B-NP	O
26	11	life	NN	O	I-NP	O
26	12	clock	NN	O	I-NP	O
26	13	COMMA	COMMA	O	O	O
26	14	we	PRP	O	B-NP	O
26	15	've	VBP	O	B-VP	O
26	16	cured	VBN	O	I-VP	O
26	17	you	PRP	O	B-NP	O
26	18	COMMA	COMMA	O	O	O
26	19	and	CC	O	O	O
26	20	it	PRP	O	B-NP	O
26	21	may	MD	O	B-VP	O
26	22	not	RB	O	I-VP	O
26	23	involve	VB	O	I-VP	O
26	24	cutting	VBG	O	I-VP	O
26	25	the	DT	O	B-NP	O
26	26	prostate	NN	O	I-NP	B-Jour
26	27	out	IN	O	O	O
26	28	in	IN	O	B-PP	O
26	29	all	DT	O	B-NP	O
26	30	men	NNS	O	I-NP	O
26	31	.	.	O	O	O
26	32	''	''	O	O	O

27	0	``	``	O	O	O
27	1	A	DT	O	B-NP	O
27	2	cure	NN	O	I-NP	O
27	3	in	IN	O	B-PP	O
27	4	prostate	NN	O	B-NP	B-Jour
27	5	cancer	NN	O	I-NP	B-Medical
27	6	means	VBZ	O	B-VP	O
27	7	that	IN	O	O	O
27	8	we	PRP	O	B-NP	O
27	9	are	VBP	O	B-VP	O
27	10	going	VBG	O	I-VP	O
27	11	to	TO	O	I-VP	O
27	12	allow	VB	O	I-VP	O
27	13	you	PRP	O	B-NP	O
27	14	to	TO	O	B-VP	O
27	15	get	VB	O	I-VP	O
27	16	to	TO	O	I-VP	O
27	17	be	VB	O	I-VP	O
27	18	a	DT	O	B-NP	O
27	19	very	RB	O	I-NP	O
27	20	old	JJ	O	I-NP	O
27	21	man	NN	O	I-NP	O
27	22	and	CC	O	O	O
27	23	die	VBP	O	B-VP	O
27	24	of	IN	O	B-PP	O
27	25	something	NN	O	B-NP	O
27	26	other	JJ	O	O	O
27	27	than	IN	O	B-PP	O
27	28	prostate	NN	O	O	B-Jour
27	29	cancerCOMMA	NN	O	O	O
27	30	''	''	O	O	O
27	31	Partin	NNP	O	B-NP	B-Peop
27	32	said	VBD	O	B-VP	O
27	33	.	.	O	O	O

28	0	Typically	RB	O	O	O
28	1	COMMA	COMMA	O	O	O
28	2	prostate	NN	O	B-NP	B-Jour
28	3	cancer	NN	O	I-NP	B-Medical
28	4	is	VBZ	O	B-VP	O
28	5	discovered	VBN	O	I-VP	O
28	6	through	IN	O	B-PP	O
28	7	a	DT	O	B-NP	O
28	8	digital	JJ	O	I-NP	O
28	9	rectal	JJ	O	I-NP	B-Medical
28	10	exam	NN	O	I-NP	O
28	11	and	CC	O	O	O
28	12	a	DT	O	B-NP	O
28	13	blood	NN	O	I-NP	O
28	14	test	NN	O	I-NP	O
28	15	that	IN	O	B-NP	O
28	16	measures	NNS	O	B-VP	O
28	17	the	DT	O	B-NP	O
28	18	amount	NN	O	I-NP	O
28	19	of	IN	O	B-PP	O
28	20	prostate	NN	O	B-NP	B-Jour
28	21	specific	JJ	O	I-NP	O
28	22	antigen	NN	O	I-NP	B-Medical
28	23	-LBR-	-LBR-	O	O	O
28	24	PSA	NNP	O	O	O
28	25	-RBR-	-RBR-	O	O	O
28	26	.	.	O	O	O

29	0	For	IN	O	B-PP	O
29	1	most	JJS	O	B-NP	O
29	2	men	NNS	O	I-NP	O
29	3	who	WP	O	B-NP	O
29	4	are	VBP	O	B-VP	O
29	5	not	RB	O	O	O
29	6	elderly	JJ	O	O	O
29	7	COMMA	COMMA	O	O	O
29	8	a	DT	O	B-NP	O
29	9	PSA	NNP	O	I-NP	O
29	10	reading	NN	O	I-NP	O
29	11	above	IN	O	B-PP	O
29	12	10	CD	O	B-NP	B-Num
29	13	nanograms	NNS	O	I-NP	O
29	14	per	IN	O	B-PP	O
29	15	milliliter	NN	O	B-NP	O
29	16	-LBR-	-LBR-	O	O	O
29	17	ng/ml	NN	O	O	O
29	18	-RBR-	-RBR-	O	O	O
29	19	will	MD	O	B-VP	O
29	20	lead	VB	O	I-VP	O
29	21	the	DT	O	B-NP	O
29	22	physician	NN	O	I-NP	B-ProfTitle
29	23	to	TO	O	B-VP	O
29	24	recommend	VB	O	I-VP	O
29	25	more	RBR	O	B-NP	O
29	26	sophisticated	JJ	O	I-NP	O
29	27	and	CC	O	I-NP	O
29	28	expensive	JJ	O	I-NP	O
29	29	diagnostic	JJ	O	I-NP	O
29	30	procedures	NNS	O	I-NP	O
29	31	.	.	O	O	O

30	0	Depending	VBG	O	B-PP	O
30	1	on	IN	O	B-PP	O
30	2	the	DT	O	B-NP	O
30	3	man	NN	O	I-NP	O
30	4	's	POS	O	B-NP	O
30	5	age	NN	O	I-NP	O
30	6	and	CC	O	O	O
30	7	the	DT	O	B-NP	O
30	8	doctor	NN	O	I-NP	B-ProfTitle
30	9	's	POS	O	B-NP	O
30	10	policy	NN	O	I-NP	O
30	11	COMMA	COMMA	O	O	O
30	12	a	DT	O	B-NP	O
30	13	PSA	NNP	O	I-NP	O
30	14	reading	NN	O	I-NP	O
30	15	in	IN	O	B-PP	O
30	16	the	DT	O	B-NP	O
30	17	borderline	NN	O	I-NP	O
30	18	zone	NN	O	I-NP	O
30	19	of	IN	O	B-PP	O
30	20	4	CD	O	B-NP	B-Num
30	21	to	TO	O	I-NP	O
30	22	10	CD	O	I-NP	B-Num
30	23	ng/ml	NN	O	I-NP	O
30	24	also	RB	O	O	O
30	25	may	MD	O	B-VP	O
30	26	trigger	VB	O	I-VP	O
30	27	additional	JJ	O	B-NP	O
30	28	tests	NNS	O	I-NP	O
30	29	.	.	O	O	O

31	0	Those	DT	O	B-NP	O
31	1	tests	NNS	O	I-NP	O
31	2	typically	RB	O	O	O
31	3	include	VBP	O	B-VP	O
31	4	:	:	O	O	O

32	0	_	NN	O	B-VP	O
32	1	A	DT	O	B-NP	O
32	2	six-needle	NN	O	I-NP	O
32	3	biopsy	NN	O	I-NP	B-Medical
32	4	of	IN	O	B-PP	O
32	5	the	DT	O	B-NP	O
32	6	prostate	NN	O	I-NP	B-Jour
32	7	.	.	O	O	O

33	0	This	DT	O	B-NP	O
33	1	will	MD	O	B-VP	O
33	2	confirm	VB	O	I-VP	O
33	3	whether	IN	O	O	O
33	4	cancer	NN	O	B-NP	B-Medical
33	5	is	VBZ	O	B-VP	O
33	6	present	JJ	O	O	O
33	7	in	IN	O	B-PP	O
33	8	the	DT	O	B-NP	O
33	9	gland	NN	O	I-NP	O
33	10	.	.	O	O	O

34	0	If	IN	O	O	O
34	1	it	PRP	O	B-NP	O
34	2	is	VBZ	O	B-VP	O
34	3	COMMA	COMMA	O	O	O
34	4	the	DT	O	B-NP	O
34	5	biopsy	NN	O	I-NP	B-Medical
34	6	is	VBZ	O	B-VP	O
34	7	graded	VBN	O	I-VP	O
34	8	by	IN	O	B-PP	O
34	9	a	DT	O	B-NP	O
34	10	pathologist	NN	O	I-NP	B-ProfTitle
34	11	on	IN	O	B-PP	O
34	12	a	DT	O	B-NP	O
34	13	scale	NN	O	I-NP	O
34	14	known	VBN	O	B-VP	O
34	15	as	IN	O	B-PP	O
34	16	the	DT	O	B-NP	O
34	17	Gleason	NNP	O	I-NP	B-Peop
34	18	score	NN	O	I-NP	O
34	19	.	.	O	O	O

35	0	In	IN	O	B-PP	O
35	1	general	JJ	O	O	B-ProfTitle
35	2	COMMA	COMMA	O	O	O
35	3	Gleason	NNP	O	B-NP	B-Peop
35	4	scores	VBZ	O	O	O
35	5	of	IN	O	B-PP	O
35	6	2	CD	O	B-NP	B-Num
35	7	to	TO	O	I-NP	O
35	8	4	CD	O	I-NP	B-Num
35	9	indicate	VBP	O	B-VP	B-Medical
35	10	less	RBR	O	B-NP	O
35	11	dangerous	JJ	O	I-NP	O
35	12	tumors	NNS	O	I-NP	O
35	13	in	IN	O	B-PP	O
35	14	their	PP$	O	B-NP	O
35	15	early	JJ	O	I-NP	O
35	16	stages	NNS	O	I-NP	O
35	17	COMMA	COMMA	O	O	O
35	18	while	IN	O	O	O
35	19	scores	NNS	O	B-NP	O
35	20	of	IN	O	B-PP	O
35	21	8	CD	O	B-NP	B-Num
35	22	to	TO	O	I-NP	O
35	23	10	CD	O	I-NP	B-Num
35	24	indicate	VBP	O	B-VP	B-Medical
35	25	aggressive	JJ	O	B-NP	O
35	26	cancers	NNS	O	I-NP	O
35	27	.	.	O	O	O

36	0	Values	NNP	O	B-NP	O
36	1	of	IN	O	B-PP	O
36	2	5	CD	O	B-NP	B-Num
36	3	to	TO	O	I-NP	O
36	4	7	CD	O	I-NP	B-Num
36	5	are	VBP	O	B-VP	O
36	6	borderline	NN	O	B-NP	O
36	7	.	.	O	O	O

37	0	&	CC	O	O	O
37	1	UR	NNP	O	B-NP	O
37	2	;	:	O	O	O
37	3	MORE	JJR	O	O	O
37	4	&	CC	O	O	O
37	5	LR	NNP	O	B-NP	O
37	6	;	:	O	O	O
37	7	&	CC	O	O	O
37	8	QL	NNP	O	B-NP	O
37	9	;	:	O	O	O

38	0	_	NN	O	O	O
38	1	Ultrasound	NNP	O	B-NP	B-Org
38	2	and	CC	O	O	O
38	3	MRI	NNP	O	B-NP	B-Org
38	4	scans	NNS	O	I-NP	O
38	5	of	IN	O	B-PP	O
38	6	the	DT	O	B-NP	O
38	7	prostate	NN	O	I-NP	B-Jour
38	8	COMMA	COMMA	O	O	O
38	9	and	CC	O	O	O
38	10	a	DT	O	B-NP	O
38	11	CT	NN	O	I-NP	B-LocStat
38	12	scan	NN	O	I-NP	O
38	13	of	IN	O	B-PP	O
38	14	the	DT	O	B-NP	O
38	15	surrounding	VBG	O	I-NP	O
38	16	pelvic	JJ	O	I-NP	B-Medical
38	17	area	NN	O	I-NP	O
38	18	;	:	O	O	O

39	0	_	NN	O	B-VP	O
39	1	A	DT	O	B-NP	O
39	2	nuclear	JJ	O	I-NP	O
39	3	medicine	NN	O	I-NP	B-Medical
39	4	bone	NN	O	I-NP	O
39	5	scan	VBP	O	B-VP	O
39	6	to	TO	O	I-VP	O
39	7	determine	VB	O	I-VP	O
39	8	if	IN	O	O	O
39	9	the	DT	O	B-NP	O
39	10	cancer	NN	O	I-NP	B-Medical
39	11	has	VBZ	O	B-VP	O
39	12	spread	VBN	O	I-VP	O
39	13	to	TO	O	B-PP	O
39	14	the	DT	O	B-NP	O
39	15	skeleton	NN	O	I-NP	O
39	16	COMMA	COMMA	O	O	O
39	17	a	DT	O	B-NP	O
39	18	favorite	JJ	O	I-NP	O
39	19	resting	JJ	O	I-NP	O
39	20	ground	NN	O	I-NP	O
39	21	for	IN	O	B-PP	O
39	22	prostate	NN	O	B-NP	B-Jour
39	23	cancer	NN	O	I-NP	B-Medical
39	24	outside	IN	O	B-PP	O
39	25	the	DT	O	B-NP	O
39	26	gland	NN	O	I-NP	O
39	27	.	.	O	O	O

40	0	_	NN	O	O	O
40	1	Surgery	NNP	O	B-NP	O
40	2	to	TO	O	B-VP	O
40	3	determine	VB	O	I-VP	O
40	4	if	IN	O	O	O
40	5	the	DT	O	B-NP	O
40	6	cancer	NN	O	I-NP	B-Medical
40	7	has	VBZ	O	B-VP	O
40	8	spread	VBN	O	I-VP	O
40	9	beyond	IN	O	B-PP	O
40	10	the	DT	O	B-NP	O
40	11	gland	NN	O	I-NP	O
40	12	to	TO	O	B-PP	O
40	13	nearby	JJ	O	B-NP	O
40	14	pelvic	JJ	O	I-NP	B-Medical
40	15	lymph	NN	O	I-NP	O
40	16	nodes	NNS	O	I-NP	O
40	17	.	.	O	O	O

41	0	_	NN	O	O	O
41	1	A	DT	O	B-NP	O
41	2	DNA	NNP	O	I-NP	B-Org
41	3	ploidy	NN	O	I-NP	O
41	4	analysis	NN	O	I-NP	B-Medical
41	5	that	WDT	O	B-NP	O
41	6	helps	VBZ	O	B-VP	O
41	7	assess	VBP	O	I-VP	O
41	8	how	WRB	O	O	O
41	9	fast	JJ	O	B-NP	O
41	10	prostate	NN	O	I-NP	B-Jour
41	11	cells	NNS	O	I-NP	O
41	12	are	VBP	O	B-VP	O
41	13	growing	VBG	O	I-VP	O
41	14	.	.	O	O	O

42	0	Based	VBN	O	B-PP	O
42	1	on	IN	O	B-PP	O
42	2	these	DT	O	B-NP	O
42	3	tests	NNS	O	I-NP	O
42	4	COMMA	COMMA	O	O	O
42	5	the	DT	O	B-NP	O
42	6	physician	NN	O	I-NP	B-ProfTitle
42	7	computes	VBZ	O	B-VP	O
42	8	the	DT	O	B-NP	O
42	9	probability	NN	O	I-NP	O
42	10	that	IN	O	O	O
42	11	the	DT	O	B-NP	O
42	12	disease	NN	O	I-NP	B-Medical
42	13	is	VBZ	O	B-VP	O
42	14	confined	VBN	O	I-VP	O
42	15	to	TO	O	B-PP	O
42	16	the	DT	O	B-NP	O
42	17	organ	NN	O	I-NP	O
42	18	and	CC	O	O	O
42	19	assigns	VBZ	O	B-VP	O
42	20	a	DT	O	B-NP	O
42	21	code	NN	O	I-NP	O
42	22	to	TO	O	B-PP	O
42	23	the	DT	O	B-NP	O
42	24	results	NNS	O	I-NP	O
42	25	.	.	O	O	O

43	0	A	DT	O	B-NP	O
43	1	T1	NNP	O	I-NP	B-Money
43	2	or	CC	O	I-NP	O
43	3	T2	NNP	O	I-NP	B-Money
43	4	cancer	NN	O	I-NP	B-Medical
43	5	means	VBZ	O	B-VP	O
43	6	the	DT	O	B-NP	O
43	7	doctor	NN	O	I-NP	B-ProfTitle
43	8	believes	VBZ	O	B-VP	O
43	9	the	DT	O	B-NP	O
43	10	disease	NN	O	I-NP	B-Medical
43	11	is	VBZ	O	B-VP	O
43	12	confined	VBN	O	I-VP	O
43	13	to	TO	O	B-PP	O
43	14	the	DT	O	B-NP	O
43	15	prostate	NN	O	I-NP	B-Jour
43	16	COMMA	COMMA	O	O	O
43	17	while	IN	O	O	O
43	18	a	DT	O	B-NP	O
43	19	T3	NNP	O	I-NP	B-Money
43	20	or	CC	O	I-NP	O
43	21	T4	NNP	O	I-NP	B-Money
43	22	cancer	NN	O	I-NP	B-Medical
43	23	means	VBZ	O	B-VP	O
43	24	the	DT	O	B-NP	O
43	25	cancer	NN	O	I-NP	B-Medical
43	26	has	VBZ	O	B-VP	O
43	27	spread	VBN	O	I-VP	O
43	28	to	TO	O	B-PP	O
43	29	surrounding	VBG	O	O	O
43	30	tissue	NN	O	B-NP	O
43	31	.	.	O	O	O

44	0	An	DT	O	B-NP	O
44	1	N+	NNP	O	I-NP	O
44	2	tumor	NN	O	I-NP	O
44	3	means	VBZ	O	B-VP	O
44	4	the	DT	O	B-NP	O
44	5	cancer	NN	O	I-NP	B-Medical
44	6	has	VBZ	O	B-VP	O
44	7	spread	VBN	O	I-VP	O
44	8	beyond	IN	O	B-PP	O
44	9	the	DT	O	B-NP	O
44	10	gland	NN	O	I-NP	O
44	11	to	TO	O	B-PP	O
44	12	lymph	NN	O	B-NP	O
44	13	nodes	NNS	O	I-NP	O
44	14	and	CC	O	O	O
44	15	an	DT	O	B-NP	O
44	16	M+	NNP	O	I-NP	O
44	17	cancer	NN	O	I-NP	B-Medical
44	18	COMMA	COMMA	O	O	O
44	19	the	DT	O	B-NP	O
44	20	most	JJS	O	I-NP	O
44	21	advanced	VBN	O	I-NP	O
44	22	stage	NN	O	I-NP	O
44	23	COMMA	COMMA	O	O	O
44	24	indicates	VBZ	O	B-VP	O
44	25	that	IN	O	O	O
44	26	the	DT	O	B-NP	O
44	27	cancer	NN	O	I-NP	B-Medical
44	28	has	VBZ	O	B-VP	O
44	29	migrated	VBN	O	I-VP	O
44	30	to	TO	O	B-PP	O
44	31	bones	NNS	O	B-NP	O
44	32	or	CC	O	O	O
44	33	distant	JJ	O	B-NP	O
44	34	organs	NNS	O	I-NP	O
44	35	.	.	O	O	O

45	0	This	DT	O	B-NP	O
45	1	``	``	O	I-NP	O
45	2	staging	NN	O	I-NP	O
45	3	''	''	O	O	O
45	4	of	IN	O	B-PP	O
45	5	the	DT	O	B-NP	O
45	6	cancer	NN	O	I-NP	B-Medical
45	7	is	VBZ	O	B-VP	O
45	8	not	RB	O	O	O
45	9	100	CD	O	B-NP	B-NumPercent
45	10	percent	NN	O	I-NP	I-NumPercent
45	11	accurate	JJ	O	I-NP	O
45	12	COMMA	COMMA	O	I-NP	O
45	13	Shipley	NNP	O	I-NP	B-OrgCorp
45	14	points	VBZ	O	B-VP	O
45	15	out	IN	O	O	O
45	16	.	.	O	O	O

46	0	Many	JJ	O	B-NP	O
46	1	men	NNS	O	I-NP	O
46	2	who	WP	O	B-NP	O
46	3	are	VBP	O	B-VP	O
46	4	believed	VBN	O	I-VP	O
46	5	to	TO	O	I-VP	O
46	6	have	VB	O	I-VP	O
46	7	organ-confined	JJ	O	B-NP	O
46	8	disease	NN	O	I-NP	B-Medical
46	9	actually	RB	O	O	O
46	10	have	VBP	O	B-VP	O
46	11	cancer	NN	O	B-NP	B-Medical
46	12	that	WDT	O	B-NP	O
46	13	has	VBZ	O	B-VP	O
46	14	spread	VBN	O	I-VP	O
46	15	outside	IN	O	B-PP	O
46	16	the	DT	O	B-NP	O
46	17	gland	NN	O	I-NP	O
46	18	.	.	O	O	O

47	0	If	IN	O	O	O
47	1	the	DT	O	B-NP	O
47	2	cancer	NN	O	I-NP	B-Medical
47	3	is	VBZ	O	B-VP	O
47	4	confined	VBN	O	I-VP	O
47	5	to	TO	O	B-PP	O
47	6	the	DT	O	B-NP	O
47	7	gland	NN	O	I-NP	O
47	8	COMMA	COMMA	O	I-NP	O
47	9	surgery	NN	O	I-NP	O
47	10	or	CC	O	O	O
47	11	some	DT	O	B-NP	O
47	12	form	NN	O	I-NP	O
47	13	of	IN	O	B-PP	O
47	14	radiation	NN	O	B-NP	O
47	15	are	VBP	O	B-VP	O
47	16	the	DT	O	B-NP	O
47	17	most	RBS	O	I-NP	O
47	18	common	JJ	O	I-NP	O
47	19	treatments	NNS	O	I-NP	O
47	20	and	CC	O	O	O
47	21	can	MD	O	B-VP	O
47	22	effectively	RB	O	I-VP	O
47	23	cure	VB	O	I-VP	O
47	24	the	DT	O	B-NP	O
47	25	patient	NN	O	I-NP	B-Medical
47	26	.	.	O	O	O

48	0	Both	DT	O	B-NP	O
48	1	treatments	NNS	O	I-NP	O
48	2	are	VBP	O	B-VP	O
48	3	particularly	RB	O	O	O
48	4	effective	JJ	O	O	O
48	5	against	IN	O	B-PP	O
48	6	small	JJ	O	B-NP	O
48	7	tumors	NNS	O	I-NP	O
48	8	with	IN	O	B-PP	O
48	9	Gleason	NNP	O	B-NP	B-Peop
48	10	scores	VBZ	O	O	O
48	11	of	IN	O	B-PP	O
48	12	6	CD	O	B-NP	B-Num
48	13	or	CC	O	I-NP	O
48	14	less	JJR	O	I-NP	O
48	15	and	CC	O	I-NP	O
48	16	PSA	NNP	O	I-NP	B-Org
48	17	values	NNS	O	I-NP	O
48	18	under	IN	O	B-PP	O
48	19	10	CD	O	B-NP	B-Num
48	20	ng/ml	NN	O	I-NP	O
48	21	.	.	O	O	O

49	0	Prior	RB	O	O	B-Peop
49	1	to	TO	O	B-PP	O
49	2	surgery	NN	O	B-NP	O
49	3	or	CC	O	I-NP	O
49	4	radiation	NN	O	I-NP	O
49	5	COMMA	COMMA	O	O	O
49	6	doctors	NNS	O	B-NP	B-ProfTitle
49	7	may	MD	O	B-VP	O
49	8	use	VB	O	I-VP	O
49	9	drugs	NNS	O	B-NP	O
49	10	to	TO	O	B-VP	O
49	11	temporarily	RB	O	I-VP	O
49	12	halt	VB	O	I-VP	O
49	13	the	DT	O	B-NP	O
49	14	body	NN	O	I-NP	O
49	15	's	POS	O	B-NP	O
49	16	production	NN	O	I-NP	O
49	17	of	IN	O	B-PP	O
49	18	testosterone	NN	O	B-NP	O
49	19	in	IN	O	O	O
49	20	order	NN	O	O	O
49	21	to	TO	O	B-VP	O
49	22	shrink	VB	O	I-VP	B-ProfTitle
49	23	the	DT	O	B-NP	O
49	24	tumors	NNS	O	I-NP	O
49	25	COMMA	COMMA	O	O	O
49	26	a	DT	O	B-NP	O
49	27	procedure	NN	O	I-NP	O
49	28	known	VBN	O	B-VP	O
49	29	as	IN	O	B-PP	O
49	30	neoadjuvant	JJ	O	B-NP	O
49	31	hormonal	JJ	O	I-NP	B-Medical
49	32	therapy	NN	O	I-NP	B-Medical
49	33	.	.	O	O	O

50	0	If	IN	O	O	O
50	1	the	DT	O	B-NP	O
50	2	cancer	NN	O	I-NP	B-Medical
50	3	has	VBZ	O	B-VP	O
50	4	escaped	VBN	O	I-VP	O
50	5	the	DT	O	B-NP	O
50	6	prostate	NN	O	I-NP	B-Jour
50	7	and	CC	O	O	O
50	8	migrated	VBN	O	B-VP	O
50	9	into	IN	O	B-PP	O
50	10	surrounding	VBG	O	B-VP	O
50	11	tissue	NN	O	B-NP	O
50	12	COMMA	COMMA	O	I-NP	O
50	13	lymph	NN	O	I-NP	O
50	14	nodes	NNS	O	I-NP	O
50	15	COMMA	COMMA	O	O	O
50	16	seminal	JJ	O	B-NP	O
50	17	vesicles	NNS	O	I-NP	O
50	18	or	CC	O	I-NP	O
50	19	bone	NN	O	I-NP	O
50	20	COMMA	COMMA	O	O	O
50	21	surgery	NN	O	B-NP	O
50	22	typically	RB	O	O	O
50	23	is	VBZ	O	B-VP	O
50	24	ruled	VBN	O	I-VP	O
50	25	out	IN	O	O	O
50	26	because	IN	O	O	O
50	27	it	PRP	O	B-NP	O
50	28	doesn	NN	O	B-NP	O
50	29	't	NN	O	I-NP	O
50	30	do	VBP	O	B-VP	O
50	31	any	DT	O	B-NP	O
50	32	good	JJ	O	I-NP	O
50	33	to	TO	O	B-VP	O
50	34	remove	VB	O	I-VP	O
50	35	the	DT	O	B-NP	O
50	36	gland	NN	O	I-NP	O
50	37	.	.	O	O	O

51	0	About	IN	O	B-NP	O
51	1	29	CD	O	I-NP	B-NumPercent
51	2	percent	NN	O	I-NP	I-NumPercent
51	3	of	IN	O	B-PP	O
51	4	all	DT	O	B-NP	O
51	5	prostate	NN	O	I-NP	B-Jour
51	6	cancer	NN	O	I-NP	B-Medical
51	7	cases	NNS	O	I-NP	O
51	8	each	DT	O	B-NP	O
51	9	year	NN	O	I-NP	O
51	10	are	VBP	O	B-VP	O
51	11	diagnosed	VBN	O	I-VP	O
51	12	in	IN	O	B-PP	O
51	13	these	DT	O	B-NP	O
51	14	more	JJR	O	I-NP	O
51	15	advanced	VBD	O	O	O
51	16	stages	NNS	O	B-NP	O
51	17	when	WRB	O	O	O
51	18	a	DT	O	B-NP	O
51	19	cure	NN	O	I-NP	O
51	20	is	VBZ	O	B-VP	O
51	21	less	RBR	O	O	O
51	22	likely	JJ	O	O	O
51	23	and	CC	O	O	O
51	24	treatment	NN	O	O	O
51	25	options	NNS	O	O	O
51	26	more	RBR	O	O	O
51	27	ambiguous	JJ	O	O	O
51	28	.	.	O	O	O

52	0	``	``	O	O	O
52	1	I	PRP	O	B-NP	O
52	2	can	MD	O	B-VP	O
52	3	see	VB	O	I-VP	O
52	4	a	DT	O	B-NP	O
52	5	45-year-old	JJ	O	I-NP	B-Num
52	6	man	NN	O	I-NP	O
52	7	with	IN	O	B-PP	O
52	8	a	DT	O	B-NP	O
52	9	very	RB	O	I-NP	O
52	10	aggressive	JJ	O	I-NP	O
52	11	tumor	NN	O	I-NP	O
52	12	COMMA	COMMA	O	O	O
52	13	and	CC	O	O	O
52	14	I	PRP	O	B-NP	O
52	15	know	VBP	O	B-VP	O
52	16	from	IN	O	B-PP	O
52	17	the	DT	O	B-NP	O
52	18	first	JJ	O	I-NP	B-Num
52	19	day	NN	O	I-NP	B-DayFest
52	20	I	PRP	O	B-NP	O
52	21	meet	VBP	O	B-VP	O
52	22	him	PRP	O	B-NP	O
52	23	that	IN	O	O	O
52	24	he	PRP	O	B-NP	O
52	25	will	MD	O	B-VP	O
52	26	not	RB	O	I-VP	O
52	27	be	VB	O	I-VP	O
52	28	curable	JJ	O	O	O
52	29	by	IN	O	B-PP	O
52	30	surgery	NN	O	B-NP	O
52	31	or	CC	O	I-NP	O
52	32	radiation	NN	O	I-NP	O
52	33	and	CC	O	I-NP	O
52	34	will	NN	O	I-NP	O
52	35	need	VB	O	B-VP	O
52	36	an	DT	O	B-NP	O
52	37	alternativeCOMMA	NN	O	I-NP	O
52	38	''	''	O	O	O
52	39	said	VBD	O	B-VP	O
52	40	Scher	NNP	O	B-NP	B-Peop
52	41	.	.	O	O	O

53	0	For	IN	O	B-PP	O
53	1	these	DT	O	B-NP	O
53	2	men	NNS	O	I-NP	O
53	3	COMMA	COMMA	O	O	O
53	4	depending	VBG	O	B-VP	O
53	5	upon	IN	O	B-PP	O
53	6	the	DT	O	B-NP	O
53	7	spread	NN	O	I-NP	O
53	8	of	IN	O	B-PP	O
53	9	the	DT	O	B-NP	O
53	10	disease	NN	O	I-NP	B-Medical
53	11	COMMA	COMMA	O	O	O
53	12	radiation	NN	O	B-NP	O
53	13	may	MD	O	B-VP	O
53	14	be	VB	O	I-VP	O
53	15	aimed	VBN	O	I-VP	O
53	16	at	IN	O	B-PP	O
53	17	the	DT	O	B-NP	O
53	18	gland	NN	O	I-NP	O
53	19	and	CC	O	O	O
53	20	the	DT	O	B-NP	O
53	21	surrounding	VBG	O	I-NP	O
53	22	area	NN	O	I-NP	O
53	23	COMMA	COMMA	O	O	O
53	24	not	RB	O	O	O
53	25	as	IN	O	B-PP	O
53	26	a	DT	O	B-NP	O
53	27	cure	NN	O	I-NP	O
53	28	but	CC	O	O	O
53	29	because	IN	O	O	O
53	30	radiation	NN	O	B-NP	O
53	31	can	MD	O	B-VP	O
53	32	kick	VB	O	I-VP	O
53	33	the	DT	O	B-NP	O
53	34	tumor	NN	O	I-NP	O
53	35	into	IN	O	B-PP	O
53	36	remission	NN	O	B-NP	O
53	37	.	.	O	O	O

54	0	Men	NNS	O	B-NP	O
54	1	with	IN	O	B-PP	O
54	2	advanced	VBN	O	B-NP	O
54	3	disease	NN	O	I-NP	B-Medical
54	4	often	RB	O	O	O
54	5	are	VBP	O	B-VP	O
54	6	treated	VBN	O	I-VP	O
54	7	to	TO	O	I-VP	O
54	8	shut	VB	O	I-VP	O
54	9	down	IN	O	O	O
54	10	their	PP$	O	B-NP	O
54	11	testosterone	NN	O	I-NP	O
54	12	COMMA	COMMA	O	O	O
54	13	the	DT	O	B-NP	O
54	14	cancer	NN	O	I-NP	B-Medical
54	15	's	POS	O	B-NP	O
54	16	main	JJ	O	I-NP	O
54	17	fuel	NN	O	I-NP	O
54	18	supply	NN	O	I-NP	O
54	19	.	.	O	O	O

55	0	But	CC	O	O	O
55	1	cutting	VBG	O	B-VP	O
55	2	off	IN	O	B-PP	O
55	3	the	DT	O	B-NP	O
55	4	hormone	NN	O	I-NP	B-Medical
55	5	supply	NN	O	I-NP	O
55	6	is	VBZ	O	B-VP	O
55	7	a	DT	O	B-NP	O
55	8	temporary	JJ	O	I-NP	O
55	9	measure	NN	O	I-NP	O
55	10	.	.	O	O	O

56	0	Eventually	RB	O	O	O
56	1	COMMA	COMMA	O	O	O
56	2	when	WRB	O	O	O
56	3	it	PRP	O	B-NP	O
56	4	enters	VBZ	O	B-VP	O
56	5	the	DT	O	B-NP	O
56	6	most	RBS	O	I-NP	O
56	7	lethal	JJ	O	I-NP	B-Medical
56	8	stage	NN	O	I-NP	O
56	9	the	DT	O	B-NP	O
56	10	cancer	NN	O	I-NP	B-Medical
56	11	transforms	VBZ	O	B-VP	O
56	12	from	IN	O	B-PP	O
56	13	a	DT	O	O	O
56	14	disease	NN	O	O	B-Medical
56	15	dependent	NN	O	O	B-Medical
56	16	on	IN	O	B-PP	O
56	17	male	JJ	O	B-NP	O
56	18	sex	NN	O	I-NP	O
56	19	hormones	NNS	O	I-NP	B-Medical
56	20	for	IN	O	B-PP	O
56	21	growth	NN	O	B-NP	O
56	22	to	TO	O	B-PP	O
56	23	a	DT	O	B-NP	O
56	24	cancer	NN	O	I-NP	B-Medical
56	25	that	WDT	O	B-NP	O
56	26	will	MD	O	B-VP	O
56	27	grow	VB	O	I-VP	O
56	28	even	RB	O	O	O
56	29	when	WRB	O	O	O
56	30	hormones	NNS	O	B-NP	B-Medical
56	31	are	VBP	O	B-VP	O
56	32	not	RB	O	O	O
56	33	present	JJ	O	O	O
56	34	.	.	O	O	O

57	0	At	IN	O	B-PP	O
57	1	this	DT	O	B-NP	O
57	2	point	NN	O	I-NP	O
57	3	COMMA	COMMA	O	O	O
57	4	further	RB	O	O	O
57	5	down	IN	O	B-PP	O
57	6	the	DT	O	B-NP	O
57	7	treatment	NN	O	I-NP	O
57	8	trail	NN	O	I-NP	O
57	9	is	VBZ	O	B-VP	O
57	10	chemotherapy	NN	O	B-NP	B-Jour
57	11	;	:	O	O	O
57	12	in	IN	O	B-PP	O
57	13	the	DT	O	B-NP	O
57	14	past	JJ	O	I-NP	O
57	15	toxins	NNS	O	I-NP	O
57	16	haven	NN	O	I-NP	O
57	17	't	NN	O	I-NP	O
57	18	been	VBN	O	B-VP	O
57	19	very	RB	O	O	O
57	20	effective	JJ	O	O	O
57	21	in	IN	O	B-PP	O
57	22	knocking	VBG	O	B-VP	O
57	23	out	IN	O	B-PP	O
57	24	prostate	NN	O	B-NP	B-Jour
57	25	cancer	NN	O	I-NP	B-Medical
57	26	but	CC	O	O	O
57	27	new	JJ	O	B-NP	O
57	28	progress	NN	O	I-NP	O
57	29	is	VBZ	O	B-VP	O
57	30	being	VBG	O	I-VP	O
57	31	reported	VBN	O	I-VP	O
57	32	.	.	O	O	O

58	0	Here	RB	O	B-NP	O
58	1	are	VBP	O	B-VP	O
58	2	the	DT	O	B-NP	O
58	3	major	JJ	O	I-NP	O
58	4	treatment	NN	O	I-NP	O
58	5	options	NNS	O	I-NP	O
58	6	facing	VBG	O	B-VP	O
58	7	the	DT	O	B-NP	O
58	8	prostate	NN	O	I-NP	B-Jour
58	9	cancer	NN	O	I-NP	B-Medical
58	10	patient	NN	O	I-NP	B-Medical
58	11	:	:	O	O	O

59	0	&	CC	O	O	O
59	1	UR	NNP	O	B-NP	O
59	2	;	:	O	O	O
59	3	-	:	O	O	O
59	4	-	:	O	O	O
59	5	-	:	O	O	O
59	6	&	CC	O	O	O
59	7	LR	NNP	O	B-NP	O
59	8	;	:	O	O	O
59	9	&	CC	O	O	O
59	10	QL	NNP	O	B-NP	O
59	11	;	:	O	O	O

60	0	&	CC	O	O	O
60	1	UR	NNP	O	B-NP	O
60	2	;	:	O	O	O
60	3	-	:	O	O	O
60	4	-	:	O	O	O
60	5	-	:	O	O	O
60	6	&	CC	O	O	O
60	7	LR	NNP	O	B-NP	O
60	8	;	:	O	O	O
60	9	&	CC	O	O	O
60	10	QL	NNP	O	B-NP	O
60	11	;	:	O	O	O

61	0	RADICAL	NNP	O	B-NP	O
61	1	PROSTATECTOMY	NNP	O	I-NP	O
61	2	:	:	O	O	O

62	0	The	DT	O	B-NP	O
62	1	surgical	JJ	O	I-NP	B-Medical
62	2	removal	NN	O	I-NP	O
62	3	of	IN	O	B-PP	O
62	4	the	DT	O	B-NP	O
62	5	prostate	NN	O	I-NP	B-Jour
62	6	COMMA	COMMA	O	O	O
62	7	a	DT	O	B-NP	O
62	8	radical	JJ	O	I-NP	O
62	9	prostatectomy	NN	O	I-NP	O
62	10	COMMA	COMMA	O	O	O
62	11	is	VBZ	O	B-VP	O
62	12	the	DT	O	B-NP	O
62	13	most	RBS	O	I-NP	O
62	14	common	JJ	O	I-NP	O
62	15	treatment	NN	O	I-NP	O
62	16	for	IN	O	B-PP	O
62	17	early-stage	JJ	O	B-NP	O
62	18	prostate	NN	O	I-NP	B-Jour
62	19	cancer	NN	O	I-NP	B-Medical
62	20	.	.	O	O	O

63	0	The	DT	O	B-NP	O
63	1	patient	NN	O	I-NP	B-Medical
63	2	must	MD	O	B-VP	O
63	3	weigh	VB	O	I-VP	O
63	4	his	PP$	O	B-NP	O
63	5	chance	NN	O	I-NP	O
63	6	for	IN	O	B-PP	O
63	7	a	DT	O	B-NP	O
63	8	cure	NN	O	I-NP	O
63	9	against	IN	O	B-PP	O
63	10	incontinence	NN	O	B-NP	B-Medical
63	11	and	CC	O	I-NP	O
63	12	impotence	NN	O	I-NP	B-Medical
63	13	.	.	O	O	O

64	0	The	DT	O	B-NP	O
64	1	operation	NN	O	I-NP	O
64	2	usually	RB	O	O	O
64	3	requires	VBZ	O	B-VP	O
64	4	several	JJ	O	B-NP	O
64	5	days	NNS	O	I-NP	O
64	6	in	IN	O	B-PP	O
64	7	the	DT	O	B-NP	O
64	8	hospital	NN	O	I-NP	O
64	9	and	CC	O	I-NP	O
64	10	weeks	NNS	O	I-NP	O
64	11	of	IN	O	B-PP	O
64	12	recuperation	NN	O	B-NP	B-Medical
64	13	.	.	O	O	O

65	0	Patients	NNS	O	B-NP	O
65	1	have	VBP	O	B-VP	O
65	2	varying	VBG	O	B-NP	O
65	3	experiences	NNS	O	I-NP	O
65	4	.	.	O	O	O

66	0	J.	NNP	O	O	O
66	1	William	NNP	O	O	B-Peop
66	2	Gadzuk	NNP	O	O	I-Peop
66	3	COMMA	COMMA	O	O	O
66	4	of	IN	O	B-PP	O
66	5	Potomac	NNP	O	B-NP	B-Loc
66	6	COMMA	COMMA	O	O	O
66	7	Md.	NNP	O	B-NP	B-LocStat
66	8	COMMA	COMMA	O	O	O
66	9	a	DT	O	B-NP	O
66	10	physicist	NN	O	I-NP	B-ProfTitle
66	11	for	IN	O	O	O
66	12	the	DT	O	B-NP	O
66	13	National	NNP	O	I-NP	B-OrgCorp
66	14	Institute	NNP	O	I-NP	I-OrgCorp
66	15	of	IN	O	B-PP	I-OrgCorp
66	16	Standards	NNPS	O	B-NP	I-OrgCorp
66	17	and	CC	O	I-NP	O
66	18	Technology	NNP	O	I-NP	B-Loc
66	19	COMMA	COMMA	O	O	O
66	20	had	VBD	O	B-VP	O
66	21	the	DT	O	B-NP	O
66	22	operation	NN	O	I-NP	O
66	23	nearly	RB	O	B-NP	O
66	24	four	CD	O	I-NP	B-Num
66	25	years	NNS	O	I-NP	B-Date
66	26	ago	IN	O	O	O
66	27	at	IN	O	B-PP	O
66	28	Johns	NNP	O	B-NP	B-OrgUniv
66	29	Hopkins	NNP	O	I-NP	I-OrgUniv
66	30	University	NNP	O	I-NP	I-OrgUniv
66	31	in	IN	O	B-PP	O
66	32	Baltimore	NNP	O	B-NP	B-LocCit
66	33	COMMA	COMMA	O	O	O
66	34	one	CD	O	B-NP	B-Num
66	35	of	IN	O	B-PP	O
66	36	the	DT	O	B-NP	O
66	37	pioneering	JJ	O	I-NP	O
66	38	institutions	NNS	O	I-NP	O
66	39	for	IN	O	B-PP	O
66	40	prostate	NN	O	B-NP	B-Jour
66	41	surgery	NN	O	I-NP	O
66	42	.	.	O	O	O

67	0	``	``	O	O	O
67	1	The	DT	O	B-NP	O
67	2	whole	JJ	O	I-NP	O
67	3	surgical	JJ	O	I-NP	B-Medical
67	4	thing	NN	O	I-NP	O
67	5	was	VBD	O	B-VP	O
67	6	remarkably	RB	O	O	O
67	7	unremarkableCOMMA	NN	O	O	O
67	8	''	''	O	O	O
67	9	Gadzuk	NNP	O	B-NP	B-Peop
67	10	said	VBD	O	B-VP	O
67	11	.	.	O	O	O

68	0	``	``	O	O	O
68	1	I	PRP	O	B-NP	O
68	2	didn	NN	O	B-NP	O
68	3	't	NN	O	I-NP	O
68	4	have	VBP	O	B-VP	O
68	5	a	DT	O	B-NP	O
68	6	lot	NN	O	I-NP	O
68	7	of	IN	O	B-PP	O
68	8	discomfort	NN	O	B-NP	O
68	9	or	CC	O	O	O
68	10	a	DT	O	B-NP	O
68	11	lot	NN	O	I-NP	O
68	12	of	IN	O	B-PP	O
68	13	pain	NN	O	B-NP	O
68	14	.	.	O	O	O
68	15	''	''	O	O	O

69	0	However	RB	O	O	O
69	1	COMMA	COMMA	O	O	O
69	2	Gadzuk	NNP	O	B-NP	B-Peop
69	3	said	VBD	O	B-VP	O
69	4	he	PRP	O	B-NP	O
69	5	was	VBD	O	B-VP	O
69	6	left	VBN	O	I-VP	O
69	7	with	IN	O	B-PP	O
69	8	sexual	JJ	O	B-NP	O
69	9	dysfunction	NN	O	I-NP	B-Medical
69	10	COMMA	COMMA	O	O	O
69	11	even	RB	O	O	O
69	12	though	IN	O	O	O
69	13	Johns	NNP	O	B-NP	O
69	14	Hopkins	NNP	O	I-NP	O
69	15	surgeons	NNS	O	I-NP	B-ProfTitle
69	16	have	VBP	O	B-VP	O
69	17	developed	VBN	O	I-VP	O
69	18	a	DT	O	B-NP	O
69	19	technique	NN	O	I-NP	O
69	20	to	TO	O	B-VP	O
69	21	protect	VB	O	I-VP	O
69	22	the	DT	O	B-NP	O
69	23	erection	NN	O	I-NP	B-Medical
69	24	nerves	NNS	O	I-NP	O
69	25	located	VBN	O	B-VP	O
69	26	near	IN	O	B-PP	O
69	27	the	DT	O	B-NP	O
69	28	gland	NN	O	I-NP	O
69	29	.	.	O	O	O

70	0	``	``	O	O	O
70	1	That	DT	O	B-NP	O
70	2	has	VBZ	O	B-VP	O
70	3	not	RB	O	I-VP	O
70	4	been	VBN	O	I-VP	O
70	5	as	RB	O	O	O
70	6	successful	JJ	O	O	O
70	7	as	IN	O	B-PP	O
70	8	one	CD	O	B-NP	B-Num
70	9	might	MD	O	B-VP	O
70	10	have	VB	O	I-VP	O
70	11	gathered	VBN	O	I-VP	O
70	12	from	IN	O	B-PP	O
70	13	the	DT	O	B-NP	O
70	14	hypeCOMMA	NN	O	I-NP	O
70	15	''	''	O	O	O
70	16	he	PRP	O	B-NP	O
70	17	said	VBD	O	B-VP	O
70	18	.	.	O	O	O

71	0	Author	NNP	O	B-NP	B-ProfTitle
71	1	Michael	NNP	O	I-NP	B-Peop
71	2	Koorda	NNP	O	I-NP	I-Peop
71	3	in	IN	O	B-PP	O
71	4	his	PP$	O	B-NP	O
71	5	book	NN	O	I-NP	B-Book
71	6	``	``	O	O	O
71	7	Man	NN	O	B-NP	O
71	8	to	TO	O	B-PP	O
71	9	Man	NNP	O	B-NP	O
71	10	''	''	O	O	O
71	11	described	VBD	O	B-VP	O
71	12	a	DT	O	B-NP	O
71	13	difficult	JJ	O	I-NP	O
71	14	and	CC	O	I-NP	O
71	15	often	RB	O	I-NP	O
71	16	painful	JJ	O	I-NP	O
71	17	recovery	NN	O	I-NP	O
71	18	after	IN	O	B-PP	O
71	19	surgery	NN	O	B-NP	O
71	20	at	IN	O	B-PP	O
71	21	the	DT	O	B-NP	O
71	22	same	JJ	O	I-NP	O
71	23	institution	NN	O	I-NP	O
71	24	.	.	O	O	O

72	0	Urologists	NNS	O	B-NP	O
72	1	say	VBP	O	B-VP	O
72	2	a	DT	O	B-NP	O
72	3	patient	NN	O	I-NP	B-Medical
72	4	is	VBZ	O	B-VP	O
72	5	a	DT	O	B-NP	O
72	6	good	JJ	O	I-NP	O
72	7	surgical	JJ	O	I-NP	B-Medical
72	8	candidate	NN	O	I-NP	O
72	9	if	IN	O	O	O
72	10	he	PRP	O	B-NP	O
72	11	is	VBZ	O	B-VP	O
72	12	under	IN	O	B-PP	O
72	13	age	NN	O	B-NP	O
72	14	70	CD	O	I-NP	B-Num
72	15	COMMA	COMMA	O	O	O
72	16	in	IN	O	B-PP	O
72	17	good	JJ	O	B-NP	O
72	18	health	NN	O	I-NP	O
72	19	COMMA	COMMA	O	O	O
72	20	with	IN	O	B-PP	O
72	21	the	DT	O	B-NP	O
72	22	cancer	NN	O	I-NP	B-Medical
72	23	confined	VBN	O	O	O
72	24	to	TO	O	B-PP	O
72	25	his	PP$	O	B-NP	O
72	26	gland	NN	O	I-NP	O
72	27	and	CC	O	O	O
72	28	if	IN	O	O	O
72	29	he	PRP	O	B-NP	O
72	30	can	MD	O	B-VP	O
72	31	deal	VB	O	I-VP	O
72	32	with	IN	O	B-PP	O
72	33	the	DT	O	B-NP	O
72	34	possible	JJ	O	I-NP	O
72	35	side	NN	O	I-NP	O
72	36	effects	NNS	O	I-NP	O
72	37	.	.	O	O	O

73	0	&	CC	O	O	O
73	1	UR	NNP	O	B-NP	O
73	2	;	:	O	O	O
73	3	-	:	O	O	O
73	4	-	:	O	O	O
73	5	-	:	O	O	O
73	6	&	CC	O	O	O
73	7	LR	NNP	O	B-NP	O
73	8	;	:	O	O	O
73	9	&	CC	O	O	O
73	10	QL	NNP	O	B-NP	O
73	11	;	:	O	O	O

74	0	&	CC	O	O	O
74	1	UR	NNP	O	B-NP	O
74	2	;	:	O	O	O
74	3	-	:	O	O	O
74	4	-	:	O	O	O
74	5	-	:	O	O	O
74	6	&	CC	O	O	O
74	7	LR	NNP	O	B-NP	O
74	8	;	:	O	O	O
74	9	&	CC	O	O	O
74	10	QL	NNP	O	B-NP	O
74	11	;	:	O	O	O

75	0	RADIATION	NNP	O	B-NP	O
75	1	:	:	O	O	O

76	0	There	EX	O	B-NP	O
76	1	is	VBZ	O	B-VP	O
76	2	little	JJ	O	B-NP	O
76	3	or	CC	O	I-NP	O
76	4	no	DT	O	I-NP	O
76	5	pain	NN	O	I-NP	O
76	6	associated	VBD	O	B-VP	O
76	7	with	IN	O	B-PP	O
76	8	radiation	NN	O	B-NP	O
76	9	.	.	O	O	O

77	0	However	RB	O	O	O
77	1	COMMA	COMMA	O	O	O
77	2	impotence	NN	O	B-NP	B-Medical
77	3	COMMA	COMMA	O	I-NP	O
77	4	incontinence	NN	O	I-NP	B-Medical
77	5	and	CC	O	B-NP	O
77	6	even	RB	O	I-NP	O
77	7	bowel	NN	O	B-NP	O
77	8	scarring	NN	O	I-NP	B-Medical
77	9	are	VBP	O	B-VP	O
77	10	possible	JJ	O	B-NP	O
77	11	side	NN	O	I-NP	O
77	12	effects	NNS	O	I-NP	O
77	13	.	.	O	O	O

78	0	Another	DT	O	B-NP	O
78	1	downside	NN	O	I-NP	O
78	2	is	VBZ	O	B-VP	O
78	3	that	IN	O	O	O
78	4	there	EX	O	B-NP	O
78	5	are	VBP	O	B-VP	O
78	6	limits	NNS	O	B-NP	O
78	7	to	TO	O	B-PP	O
78	8	how	WRB	O	O	O
78	9	much	JJ	O	O	O
78	10	radiation	NN	O	O	O
78	11	can	MD	O	B-VP	O
78	12	be	VB	O	I-VP	O
78	13	focused	VBN	O	I-VP	O
78	14	on	IN	O	B-PP	O
78	15	the	DT	O	B-NP	O
78	16	same	JJ	O	I-NP	O
78	17	area	NN	O	I-NP	O
78	18	.	.	O	O	O

79	0	Too	RB	O	O	O
79	1	much	JJ	O	O	O
79	2	radiation	NN	O	O	O
79	3	can	MD	O	B-VP	O
79	4	kill	VB	O	I-VP	O
79	5	healthy	JJ	O	B-NP	O
79	6	tissue	NN	O	I-NP	O
79	7	by	IN	O	B-PP	O
79	8	damaging	JJ	O	B-NP	O
79	9	blood	NN	O	I-NP	O
79	10	flow	NN	O	I-NP	O
79	11	.	.	O	O	O

80	0	Prostate	VB	O	O	B-Jour
80	1	cancer	NN	O	B-NP	B-Medical
80	2	patient	NN	O	I-NP	B-Medical
80	3	Carl	NNP	O	I-NP	B-Peop
80	4	Silverstein	NNP	O	I-NP	I-Peop
80	5	COMMA	COMMA	O	O	O
80	6	of	IN	O	B-PP	O
80	7	Monticello	NNP	O	B-NP	B-LocStruct
80	8	COMMA	COMMA	O	O	O
80	9	N.Y.	NNP	O	B-NP	B-LocStat
80	10	COMMA	COMMA	O	O	O
80	11	opted	VBD	O	B-VP	O
80	12	for	IN	O	B-PP	O
80	13	radiation	NN	O	B-NP	O
80	14	over	IN	O	B-PP	O
80	15	surgery	NN	O	B-NP	O
80	16	when	WRB	O	O	O
80	17	he	PRP	O	B-NP	O
80	18	was	VBD	O	B-VP	O
80	19	diagnosed	VBN	O	I-VP	O
80	20	in	IN	O	B-PP	O
80	21	1995	CD	O	B-NP	B-Date
80	22	.	.	O	O	O

81	0	A	DT	O	B-NP	O
81	1	semi-retired	JJ	O	I-NP	O
81	2	lawyer	NN	O	I-NP	B-ProfTitle
81	3	for	IN	O	B-PP	O
81	4	the	DT	O	B-NP	O
81	5	Sullivan	NNP	O	I-NP	B-Loc
81	6	County	NNP	O	I-NP	I-Loc
81	7	legal	JJ	O	I-NP	O
81	8	aid	NN	O	I-NP	O
81	9	society	NN	O	I-NP	O
81	10	COMMA	COMMA	O	O	O
81	11	Silverstein	NNP	O	B-NP	B-Peop
81	12	COMMA	COMMA	O	O	O
81	13	69	CD	O	B-NP	B-Num
81	14	COMMA	COMMA	O	O	O
81	15	felt	VBD	O	B-VP	O
81	16	his	PP$	O	O	O
81	17	chances	NNS	O	B-NP	O
81	18	of	IN	O	B-PP	O
81	19	avoiding	VBG	O	B-VP	O
81	20	incontinence	NN	O	B-NP	B-Medical
81	21	and	CC	O	I-NP	O
81	22	impotence	NN	O	I-NP	B-Medical
81	23	were	VBD	O	B-VP	O
81	24	better	JJR	O	O	O
81	25	with	IN	O	B-PP	O
81	26	radiation	NN	O	B-NP	O
81	27	.	.	O	O	O

82	0	Silverstein	NNP	O	B-NP	B-Peop
82	1	underwent	VBD	O	B-VP	O
82	2	37	CD	O	B-NP	B-Num
82	3	radiation	NN	O	I-NP	O
82	4	sessions	NNS	O	I-NP	O
82	5	COMMA	COMMA	O	O	O
82	6	each	DT	O	B-NP	O
82	7	lasting	JJ	O	I-NP	O
82	8	5	CD	O	I-NP	B-Num
82	9	to	TO	O	I-NP	O
82	10	10	CD	O	I-NP	B-Num
82	11	minutes	NNS	O	I-NP	I-Num
82	12	COMMA	COMMA	O	O	O
82	13	over	IN	O	B-PP	O
82	14	seven	CD	O	B-NP	B-Num
82	15	weeks	NNS	O	I-NP	O
82	16	.	.	O	O	O

83	0	``	``	O	O	O
83	1	If	IN	O	O	O
83	2	they	PRP	O	B-NP	O
83	3	didn	NN	O	B-NP	O
83	4	't	NN	O	I-NP	O
83	5	tell	VB	O	B-VP	O
83	6	me	PRP	O	B-NP	O
83	7	I	PRP	O	B-NP	O
83	8	was	VBD	O	B-VP	O
83	9	having	VBG	O	I-VP	O
83	10	radiation	NN	O	B-NP	O
83	11	COMMA	COMMA	O	O	O
83	12	I	PRP	O	B-NP	O
83	13	'd	MD	O	B-VP	O
83	14	think	VB	O	I-VP	O
83	15	it	PRP	O	B-NP	O
83	16	was	VBD	O	B-VP	O
83	17	a	DT	O	B-NP	O
83	18	fraud	NN	O	I-NP	O
83	19	.	.	O	O	O

84	0	It	PRP	O	B-NP	O
84	1	was	VBD	O	B-VP	O
84	2	painlessCOMMA	NN	O	B-NP	O
84	3	''	''	O	I-NP	O
84	4	Silverstein	NNP	O	I-NP	B-Peop
84	5	said	VBD	O	B-VP	O
84	6	.	.	O	O	O

85	0	Unfortunately	RB	O	O	O
85	1	COMMA	COMMA	O	O	O
85	2	in	IN	O	B-PP	O
85	3	Silverstein	NNP	O	B-NP	B-Loc
85	4	's	POS	O	B-NP	O
85	5	case	NN	O	I-NP	O
85	6	COMMA	COMMA	O	O	O
85	7	the	DT	O	B-NP	O
85	8	radiation	NN	O	I-NP	O
85	9	didn	NN	O	I-NP	O
85	10	't	NN	O	I-NP	O
85	11	kill	VB	O	B-VP	O
85	12	the	DT	O	B-NP	O
85	13	cancer	NN	O	I-NP	B-Medical
85	14	.	.	O	O	O

86	0	After	IN	O	B-PP	O
86	1	his	PP$	O	B-NP	O
86	2	PSA	NNP	O	I-NP	O
86	3	started	VBD	O	B-VP	O
86	4	to	TO	O	I-VP	O
86	5	climb	VB	O	I-VP	O
86	6	again	RB	O	O	O
86	7	indicating	VBG	O	O	O
86	8	resurgent	JJ	O	B-NP	O
86	9	cancer	NN	O	I-NP	B-Medical
86	10	COMMA	COMMA	O	O	O
86	11	doctors	NNS	O	B-NP	B-ProfTitle
86	12	put	VBD	O	B-VP	O
86	13	him	PRP	O	B-NP	O
86	14	on	IN	O	B-PP	O
86	15	drugs	NNS	O	B-NP	O
86	16	to	TO	O	B-VP	O
86	17	eliminate	VB	O	I-VP	O
86	18	his	PP$	O	B-NP	O
86	19	body	NN	O	I-NP	O
86	20	's	POS	O	B-NP	O
86	21	testosterone	NN	O	I-NP	O
86	22	production	NN	O	I-NP	O
86	23	.	.	O	O	O

87	0	&	CC	O	O	O
87	1	UR	NNP	O	B-NP	O
87	2	;	:	O	O	O
87	3	MORE	JJR	O	O	O
87	4	&	CC	O	O	O
87	5	LR	NNP	O	B-NP	O
87	6	;	:	O	O	O
87	7	&	CC	O	O	O
87	8	QL	NNP	O	B-NP	O
87	9	;	:	O	O	O

88	0	Thomas	NNP	O	B-NP	B-Peop
88	1	Stephenson	NNP	O	I-NP	I-Peop
88	2	COMMA	COMMA	O	O	O
88	3	of	IN	O	B-PP	O
88	4	Chestnut	NNP	O	B-NP	B-LocMount
88	5	Hill	NNP	O	I-NP	I-LocMount
88	6	COMMA	COMMA	O	O	O
88	7	Mass.	NNP	O	B-NP	B-Loc
88	8	COMMA	COMMA	O	O	O
88	9	a	DT	O	B-NP	O
88	10	retired	VBN	O	I-NP	O
88	11	executive	NN	O	I-NP	B-ProfTitle
88	12	with	IN	O	B-PP	O
88	13	Dupont	NNP	O	B-NP	B-Peop
88	14	Co.	NNP	O	I-NP	I-Peop
88	15	COMMA	COMMA	O	O	O
88	16	is	VBZ	O	B-VP	O
88	17	a	DT	O	B-NP	O
88	18	radiation	NN	O	I-NP	O
88	19	success	NN	O	I-NP	O
88	20	story	NN	O	I-NP	O
88	21	.	.	O	O	O

89	0	He	PRP	O	B-NP	O
89	1	was	VBD	O	B-VP	O
89	2	diagnosed	VBN	O	I-VP	O
89	3	14	CD	O	B-NP	B-Num
89	4	years	NNS	O	I-NP	I-Num
89	5	ago	IN	O	O	O
89	6	at	IN	O	B-PP	O
89	7	age	NN	O	B-NP	O
89	8	69	CD	O	I-NP	B-Num
89	9	and	CC	O	O	O
89	10	underwent	VBD	O	B-VP	O
89	11	about	IN	O	B-PP	O
89	12	the	DT	O	B-NP	O
89	13	same	JJ	O	I-NP	O
89	14	number	NN	O	I-NP	O
89	15	of	IN	O	B-PP	O
89	16	sessions	NNS	O	B-NP	O
89	17	as	IN	O	B-PP	O
89	18	Silverstein	NNP	O	B-NP	B-Peop
89	19	.	.	O	O	O

90	0	His	PP$	O	B-NP	O
90	1	cancer	NN	O	I-NP	B-Medical
90	2	COMMA	COMMA	O	O	O
90	3	however	RB	O	O	O
90	4	COMMA	COMMA	O	O	O
90	5	has	VBZ	O	B-VP	O
90	6	been	VBN	O	I-VP	O
90	7	in	IN	O	B-PP	O
90	8	remission	NN	O	B-NP	O
90	9	ever	RB	O	O	O
90	10	since	IN	O	O	O
90	11	.	.	O	O	O

91	0	``	``	O	O	O
91	1	They	PRP	O	B-NP	O
91	2	won	VBD	O	B-VP	O
91	3	't	NN	O	B-NP	O
91	4	say	VBP	O	B-VP	O
91	5	that	IN	O	O	O
91	6	I	PRP	O	B-NP	O
91	7	'm	VBP	O	B-VP	O
91	8	cured	VBN	O	I-VP	O
91	9	COMMA	COMMA	O	O	O
91	10	but	CC	O	O	O
91	11	I	PRP	O	B-NP	O
91	12	've	VBP	O	B-VP	O
91	13	been	VBN	O	I-VP	O
91	14	extremely	RB	O	O	O
91	15	fortunateCOMMA	NN	O	O	O
91	16	''	''	O	O	O
91	17	he	PRP	O	B-NP	O
91	18	said	VBD	O	B-VP	O
91	19	.	.	O	O	O

92	0	&	CC	O	O	O
92	1	UR	NNP	O	B-NP	O
92	2	;	:	O	O	O
92	3	-	:	O	O	O
92	4	-	:	O	O	O
92	5	-	:	O	O	O
92	6	&	CC	O	O	O
92	7	LR	NNP	O	B-NP	O
92	8	;	:	O	O	O
92	9	&	CC	O	O	O
92	10	QL	NNP	O	B-NP	O
92	11	;	:	O	O	O

93	0	&	CC	O	O	O
93	1	UR	NNP	O	B-NP	O
93	2	;	:	O	O	O
93	3	-	:	O	O	O
93	4	-	:	O	O	O
93	5	-	:	O	O	O
93	6	&	CC	O	O	O
93	7	LR	NNP	O	B-NP	O
93	8	;	:	O	O	O
93	9	&	CC	O	O	O
93	10	QL	NNP	O	B-NP	O
93	11	;	:	O	O	O

94	0	BRACHYTHERAPY	NNP	O	O	O
94	1	OR	CC	O	O	O
94	2	SEED	NNP	O	B-NP	O
94	3	IMPLANTS	NNP	O	I-NP	O
94	4	:	:	O	O	O

95	0	Tiny	JJ	O	B-NP	B-Peop
95	1	radioactive	JJ	O	I-NP	O
95	2	implants	NNS	O	I-NP	O
95	3	COMMA	COMMA	O	O	O
95	4	no	RB	O	O	O
95	5	bigger	JJR	O	O	O
95	6	than	IN	O	O	O
95	7	a	DT	O	B-NP	O
95	8	rye	NN	O	I-NP	O
95	9	seed	NN	O	I-NP	O
95	10	and	CC	O	O	O
95	11	injected	VBD	O	B-VP	O
95	12	directly	RB	O	O	O
95	13	into	IN	O	B-PP	O
95	14	the	DT	O	B-NP	O
95	15	prostate	NN	O	I-NP	B-Jour
95	16	through	IN	O	B-PP	O
95	17	the	DT	O	B-NP	O
95	18	perineum	NN	O	I-NP	O
95	19	COMMA	COMMA	O	O	O
95	20	are	VBP	O	B-VP	O
95	21	an	DT	O	B-NP	O
95	22	increasingly	RB	O	I-NP	O
95	23	popular	JJ	O	I-NP	O
95	24	treatment	NN	O	I-NP	O
95	25	for	IN	O	B-PP	O
95	26	early-stage	JJ	O	B-NP	O
95	27	cancer	NN	O	I-NP	B-Medical
95	28	.	.	O	O	O

96	0	The	DT	O	B-NP	O
96	1	procedure	NN	O	I-NP	O
96	2	was	VBD	O	B-VP	O
96	3	tried	VBN	O	I-VP	O
96	4	since	IN	O	B-PP	O
96	5	the	DT	O	B-NP	O
96	6	1950s	CD	O	I-NP	B-Date
96	7	without	IN	O	B-PP	O
96	8	much	JJ	O	B-NP	O
96	9	success	NN	O	I-NP	O
96	10	.	.	O	O	O

97	0	After	IN	O	B-PP	O
97	1	being	VBG	O	B-VP	O
97	2	refined	VBN	O	I-VP	O
97	3	in	IN	O	B-PP	O
97	4	recent	JJ	O	B-NP	O
97	5	years	NNS	O	I-NP	B-Date
97	6	COMMA	COMMA	O	O	O
97	7	seed	NN	O	B-NP	O
97	8	therapy	NN	O	I-NP	B-Medical
97	9	is	VBZ	O	B-VP	O
97	10	coming	VBG	O	I-VP	O
97	11	back	RB	O	O	O
97	12	strong	JJ	O	O	O
97	13	.	.	O	O	O

98	0	Patient	JJ	O	B-NP	O
98	1	survival	NN	O	I-NP	O
98	2	statistics	NNS	O	I-NP	O
98	3	are	VBP	O	B-VP	O
98	4	promising	JJ	O	O	O
98	5	COMMA	COMMA	O	O	O
98	6	and	CC	O	O	O
98	7	some	DT	O	B-NP	O
98	8	doctors	NNS	O	I-NP	B-ProfTitle
98	9	believe	VBP	O	B-VP	O
98	10	it	PRP	O	B-NP	O
98	11	will	MD	O	B-VP	O
98	12	soon	RB	O	I-VP	O
98	13	become	VB	O	I-VP	O
98	14	as	RB	O	O	O
98	15	common	JJ	O	O	O
98	16	as	IN	O	B-PP	O
98	17	surgery	NN	O	B-NP	O
98	18	or	CC	O	I-NP	O
98	19	beam	NN	O	I-NP	O
98	20	radiation	NN	O	I-NP	O
98	21	.	.	O	O	O

99	0	The	DT	O	B-NP	O
99	1	seeds	NNS	O	I-NP	O
99	2	COMMA	COMMA	O	O	O
99	3	which	WDT	O	B-NP	O
99	4	remain	VBP	O	B-VP	O
99	5	permanently	RB	O	O	O
99	6	embedded	VBN	O	O	O
99	7	COMMA	COMMA	O	O	O
99	8	deliver	VBP	O	B-VP	O
99	9	a	DT	O	B-NP	O
99	10	radioactive	JJ	O	I-NP	O
99	11	dose	NN	O	I-NP	B-Medical
99	12	inside	IN	O	B-PP	O
99	13	the	DT	O	B-NP	O
99	14	gland	NN	O	I-NP	O
99	15	for	IN	O	B-PP	O
99	16	up	IN	O	O	O
99	17	to	TO	O	B-PP	O
99	18	a	DT	O	B-NP	O
99	19	year	NN	O	I-NP	O
99	20	COMMA	COMMA	O	O	O
99	21	burning	VBG	O	B-VP	O
99	22	out	IN	O	O	O
99	23	the	DT	O	B-NP	O
99	24	prostate	NN	O	I-NP	B-Jour
99	25	COMMA	COMMA	O	O	O
99	26	and	CC	O	O	O
99	27	COMMA	COMMA	O	O	O
99	28	hopefully	RB	O	O	O
99	29	COMMA	COMMA	O	O	O
99	30	the	DT	O	B-NP	O
99	31	cancer	NN	O	I-NP	B-Medical
99	32	with	IN	O	B-PP	O
99	33	it	PRP	O	B-NP	O
99	34	.	.	O	O	O

100	0	A	DT	O	B-NP	O
100	1	major	JJ	O	I-NP	O
100	2	benefit	NN	O	I-NP	O
100	3	is	VBZ	O	B-VP	O
100	4	that	DT	O	B-NP	O
100	5	seed	NN	O	I-NP	O
100	6	implants	NNS	O	I-NP	O
100	7	are	VBP	O	B-VP	O
100	8	much	RB	O	O	O
100	9	less	JJR	O	O	O
100	10	invasive	JJ	O	O	O
100	11	than	IN	O	B-PP	O
100	12	surgery	NN	O	B-NP	O
100	13	COMMA	COMMA	O	O	O
100	14	requiring	VBG	O	B-VP	O
100	15	perhaps	RB	O	O	O
100	16	an	DT	O	B-NP	O
100	17	overnight	RB	O	I-NP	O
100	18	stay	NN	O	I-NP	O
100	19	in	IN	O	B-PP	O
100	20	the	DT	O	B-NP	O
100	21	hospital	NN	O	I-NP	O
100	22	.	.	O	O	O

101	0	As	IN	O	B-PP	O
101	1	with	IN	O	B-PP	O
101	2	traditional	JJ	O	B-NP	O
101	3	radiation	NN	O	I-NP	O
101	4	and	CC	O	I-NP	O
101	5	surgery	NN	O	I-NP	O
101	6	COMMA	COMMA	O	O	O
101	7	the	DT	O	B-NP	O
101	8	seeds	NNS	O	I-NP	O
101	9	may	MD	O	B-VP	O
101	10	impair	VB	O	I-VP	O
101	11	a	DT	O	B-NP	O
101	12	man	NN	O	I-NP	O
101	13	's	POS	O	B-NP	O
101	14	continence	NN	O	I-NP	O
101	15	and	CC	O	I-NP	O
101	16	potency	NN	O	I-NP	B-Medical
101	17	.	.	O	O	O

102	0	Some	DT	O	B-NP	O
102	1	patients	NNS	O	I-NP	O
102	2	require	VBP	O	B-VP	O
102	3	corrective	JJ	O	B-NP	O
102	4	surgery	NN	O	I-NP	O
102	5	to	TO	O	B-PP	O
102	6	the	DT	O	B-NP	O
102	7	rectum	NN	O	I-NP	O
102	8	or	CC	O	I-NP	O
102	9	urethra	NN	O	I-NP	O
102	10	after	IN	O	B-PP	O
102	11	treatment	NN	O	B-NP	O
102	12	.	.	O	O	O

103	0	If	IN	O	O	O
103	1	the	DT	O	B-NP	O
103	2	seeds	NNS	O	I-NP	O
103	3	irritate	VB	O	B-VP	O
103	4	the	DT	O	B-NP	O
103	5	urethra	NN	O	I-NP	O
103	6	COMMA	COMMA	O	O	O
103	7	which	WDT	O	B-NP	O
103	8	carries	VBZ	O	B-VP	O
103	9	urine	NN	O	B-NP	O
103	10	from	IN	O	B-PP	O
103	11	the	DT	O	B-NP	O
103	12	bladder	NN	O	I-NP	O
103	13	to	TO	O	B-PP	O
103	14	the	DT	O	B-NP	O
103	15	penis	NN	O	I-NP	B-Medical
103	16	and	CC	O	O	O
103	17	runs	VBZ	O	B-VP	O
103	18	through	IN	O	B-PP	O
103	19	the	DT	O	B-NP	O
103	20	prostate	NN	O	I-NP	B-Jour
103	21	gland	NN	O	I-NP	O
103	22	COMMA	COMMA	O	O	O
103	23	the	DT	O	B-NP	O
103	24	patient	NN	O	I-NP	B-Medical
103	25	often	RB	O	O	O
103	26	feels	VBZ	O	B-VP	O
103	27	the	DT	O	B-NP	O
103	28	need	VBP	O	I-NP	O
103	29	to	TO	O	O	O
103	30	urinate	VB	O	O	O
103	31	.	.	O	O	O

104	0	Jan	NNP	O	B-NP	B-Peop
104	1	Marfyaic	NNP	O	I-NP	I-Peop
104	2	COMMA	COMMA	O	O	O
104	3	from	IN	O	B-PP	O
104	4	Gettysburg	NNP	O	B-NP	B-Loc
104	5	COMMA	COMMA	O	O	O
104	6	Pa.	NNP	O	B-NP	B-Peop
104	7	COMMA	COMMA	O	O	O
104	8	a	DT	O	B-NP	O
104	9	former	JJ	O	I-NP	O
104	10	government	NN	O	I-NP	O
104	11	worker	NN	O	I-NP	B-ProfTitle
104	12	COMMA	COMMA	O	O	O
104	13	was	VBD	O	B-VP	O
104	14	59	CD	O	B-NP	B-Num
104	15	when	WRB	O	O	O
104	16	he	PRP	O	B-NP	O
104	17	was	VBD	O	B-VP	O
104	18	diagnosed	VBN	O	I-VP	O
104	19	six	CD	O	B-NP	B-Num
104	20	years	NNS	O	I-NP	B-Date
104	21	ago	IN	O	O	O
104	22	.	.	O	O	O

105	0	``	``	O	O	O
105	1	I	PRP	O	B-NP	O
105	2	selected	VBD	O	B-VP	O
105	3	seeds	NNS	O	B-NP	O
105	4	because	IN	O	O	O
105	5	it	PRP	O	B-NP	O
105	6	was	VBD	O	B-VP	O
105	7	much	RB	O	O	O
105	8	less	JJR	O	O	O
105	9	invasive	JJ	O	O	O
105	10	and	CC	O	O	O
105	11	was	VBD	O	B-VP	O
105	12	a	DT	O	B-NP	O
105	13	relatively	RB	O	I-NP	O
105	14	new	JJ	O	I-NP	O
105	15	treatmentCOMMA	NN	O	I-NP	O
105	16	''	''	O	O	O
105	17	he	PRP	O	B-NP	O
105	18	said	VBD	O	B-VP	O
105	19	.	.	O	O	O

106	0	``	``	O	O	O
106	1	It	PRP	O	B-NP	O
106	2	still	RB	O	O	O
106	3	has	VBZ	O	B-VP	O
106	4	drawbacks	NNS	O	B-NP	O
106	5	.	.	O	O	O

107	0	The	DT	O	B-NP	O
107	1	urgency	NN	O	I-NP	O
107	2	to	TO	O	B-PP	O
107	3	urinate	NN	O	B-NP	O
107	4	becomes	VBZ	O	B-VP	O
107	5	part	NN	O	B-NP	O
107	6	of	IN	O	B-PP	O
107	7	your	PP$	O	B-NP	O
107	8	life	NN	O	I-NP	O
107	9	.	.	O	O	O

108	0	You	PRP	O	B-NP	O
108	1	start	VBP	O	B-VP	O
108	2	planning	VBG	O	I-VP	O
108	3	your	PP$	O	B-NP	O
108	4	activities	NNS	O	I-NP	O
108	5	around	IN	O	B-PP	O
108	6	where	WRB	O	O	O
108	7	the	DT	O	B-NP	O
108	8	nearest	JJS	O	I-NP	O
108	9	bathroom	NN	O	I-NP	O
108	10	is	VBZ	O	B-VP	O
108	11	.	.	O	O	O
108	12	''	''	O	O	O

109	0	&	CC	O	O	O
109	1	UR	NNP	O	B-NP	O
109	2	;	:	O	O	O
109	3	-	:	O	O	O
109	4	-	:	O	O	O
109	5	-	:	O	O	O
109	6	&	CC	O	O	O
109	7	LR	NNP	O	B-NP	O
109	8	;	:	O	O	O
109	9	&	CC	O	O	O
109	10	QL	NNP	O	B-NP	O
109	11	;	:	O	O	O

110	0	&	CC	O	O	O
110	1	UR	NNP	O	B-NP	O
110	2	;	:	O	O	O
110	3	-	:	O	O	O
110	4	-	:	O	O	O
110	5	-	:	O	O	O
110	6	&	CC	O	O	O
110	7	LR	NNP	O	B-NP	O
110	8	;	:	O	O	O
110	9	&	CC	O	O	O
110	10	QL	NNP	O	B-NP	O
110	11	;	:	O	O	O

111	0	HORMONE	NNP	O	B-NP	O
111	1	THERAPY	NNP	O	I-NP	O
111	2	:	:	O	O	O

112	0	If	IN	O	O	O
112	1	prostate	NN	O	B-NP	B-Jour
112	2	cancer	NN	O	I-NP	B-Medical
112	3	spreads	NNS	O	I-NP	O
112	4	beyond	IN	O	B-PP	O
112	5	the	DT	O	B-NP	O
112	6	gland	NN	O	I-NP	O
112	7	COMMA	COMMA	O	O	O
112	8	a	DT	O	B-NP	O
112	9	man	NN	O	I-NP	O
112	10	usually	RB	O	O	O
112	11	is	VBZ	O	B-VP	O
112	12	considered	VBN	O	I-VP	O
112	13	incurable	JJ	O	O	O
112	14	.	.	O	O	O

113	0	In	IN	O	O	O
113	1	order	NN	O	O	O
113	2	to	TO	O	B-VP	O
113	3	slow	VB	O	I-VP	O
113	4	the	DT	O	B-NP	O
113	5	disease	NN	O	I-NP	B-Medical
113	6	COMMA	COMMA	O	O	O
113	7	doctors	NNS	O	B-NP	B-ProfTitle
113	8	focus	VBP	O	B-VP	O
113	9	on	IN	O	B-PP	O
113	10	therapies	NNS	O	B-NP	O
113	11	to	TO	O	B-VP	O
113	12	rob	VB	O	I-VP	O
113	13	the	DT	O	B-NP	O
113	14	cancer	NN	O	I-NP	B-Medical
113	15	of	IN	O	B-PP	O
113	16	testosterone	NN	O	B-NP	O
113	17	COMMA	COMMA	O	O	O
113	18	which	WDT	O	B-NP	O
113	19	fuels	VBZ	O	B-VP	O
113	20	cancer	NN	O	B-NP	B-Medical
113	21	growth	NN	O	I-NP	O
113	22	.	.	O	O	O

114	0	This	DT	O	B-NP	O
114	1	can	MD	O	B-VP	O
114	2	be	VB	O	I-VP	O
114	3	done	VBN	O	I-VP	O
114	4	through	IN	O	B-PP	O
114	5	surgical	JJ	O	B-NP	B-Medical
114	6	castration	NN	O	I-NP	B-Medical
114	7	to	TO	O	B-VP	O
114	8	remove	VB	O	I-VP	O
114	9	the	DT	O	B-NP	O
114	10	testes	NNS	O	I-NP	O
114	11	_	NN	O	I-NP	O
114	12	which	WDT	O	B-NP	O
114	13	produce	VBP	O	B-VP	O
114	14	testosterone	NN	O	B-NP	O
114	15	_	NN	O	I-NP	O
114	16	or	CC	O	B-PP	O
114	17	through	IN	O	B-PP	O
114	18	chemical	NN	O	B-NP	B-Medical
114	19	castration	NN	O	I-NP	B-Medical
114	20	by	IN	O	B-PP	O
114	21	using	VBG	O	B-VP	O
114	22	powerful	JJ	O	B-NP	O
114	23	drugs	NNS	O	I-NP	O
114	24	to	TO	O	B-VP	O
114	25	block	VB	O	I-VP	O
114	26	hormone	NN	O	B-NP	B-Medical
114	27	production	NN	O	I-NP	O
114	28	.	.	O	O	O

115	0	Shutting	VBG	O	B-VP	O
115	1	down	RB	O	O	O
115	2	testosterone	NN	O	B-NP	O
115	3	doesn	NN	O	I-NP	O
115	4	't	NN	O	I-NP	O
115	5	keep	VB	O	B-VP	O
115	6	the	DT	O	B-NP	O
115	7	cancer	NN	O	I-NP	B-Medical
115	8	at	IN	O	B-PP	O
115	9	bay	NN	O	B-NP	O
115	10	forever	RB	O	O	O
115	11	because	IN	O	O	O
115	12	the	DT	O	B-NP	O
115	13	disease	NN	O	I-NP	B-Medical
115	14	eventually	RB	O	O	O
115	15	finds	VBZ	O	B-VP	O
115	16	other	JJ	O	B-NP	O
115	17	substances	NNS	O	I-NP	O
115	18	in	IN	O	B-PP	B-Medical
115	19	the	DT	O	B-NP	I-Medical
115	20	body	NN	O	I-NP	I-Medical
115	21	to	TO	O	B-VP	O
115	22	feed	VB	O	I-VP	O
115	23	it	PRP	O	B-NP	O
115	24	.	.	O	O	O

116	0	David	NNP	O	B-NP	B-Peop
116	1	Evans	NNP	O	I-NP	I-Peop
116	2	COMMA	COMMA	O	O	O
116	3	the	DT	O	B-NP	O
116	4	retired	VBN	O	I-NP	O
116	5	diplomat	NN	O	I-NP	O
116	6	COMMA	COMMA	O	O	O
116	7	initially	RB	O	O	O
116	8	had	VBD	O	O	O
116	9	radiation	NN	O	B-NP	O
116	10	COMMA	COMMA	O	O	O
116	11	but	CC	O	O	O
116	12	the	DT	O	B-NP	O
116	13	cancer	NN	O	I-NP	B-Medical
116	14	returned	VBD	O	B-VP	O
116	15	two	CD	O	B-NP	B-Num
116	16	years	NNS	O	I-NP	B-Date
116	17	later	RB	O	O	O
116	18	and	CC	O	O	O
116	19	doctors	NNS	O	B-NP	B-ProfTitle
116	20	said	VBD	O	B-VP	O
116	21	castration	NN	O	B-NP	B-Medical
116	22	was	VBD	O	B-VP	O
116	23	essential	JJ	O	O	O
116	24	for	IN	O	B-PP	O
116	25	survival	NN	O	B-NP	O
116	26	.	.	O	O	O

117	0	``	``	O	O	O
117	1	That	DT	O	B-NP	O
117	2	was	VBD	O	B-VP	O
117	3	more	RBR	O	O	O
117	4	difficult	JJ	O	O	O
117	5	than	IN	O	B-PP	O
117	6	the	DT	O	B-NP	O
117	7	first	JJ	O	I-NP	B-Num
117	8	diagnosisCOMMA	NN	O	I-NP	O
117	9	''	''	O	I-NP	O
117	10	Evans	NNP	O	I-NP	B-Peop
117	11	said	VBD	O	B-VP	O
117	12	.	.	O	O	O

118	0	``	``	O	O	O
118	1	Once	RB	O	O	O
118	2	it	PRP	O	B-NP	O
118	3	's	VBZ	O	B-VP	O
118	4	out	IN	O	B-PP	O
118	5	of	IN	O	B-PP	O
118	6	the	DT	O	B-NP	O
118	7	prostate	NN	O	I-NP	B-Jour
118	8	COMMA	COMMA	O	O	O
118	9	then	RB	O	O	O
118	10	you	PRP	O	B-NP	O
118	11	know	VBP	O	B-VP	O
118	12	it	PRP	O	B-NP	O
118	13	's	POS	O	B-VP	O
118	14	incurable	JJ	O	O	O
118	15	and	CC	O	O	O
118	16	you	PRP	O	B-NP	O
118	17	're	VBP	O	B-VP	O
118	18	facing	VBG	O	I-VP	O
118	19	a	DT	O	B-NP	O
118	20	really	RB	O	I-NP	O
118	21	serious	JJ	O	I-NP	O
118	22	fight	NN	O	I-NP	O
118	23	.	.	O	O	O
118	24	''	''	O	O	O

119	0	Evans	NNP	O	B-NP	B-Peop
119	1	chose	VBD	O	B-VP	O
119	2	chemical	NN	O	B-NP	B-Medical
119	3	castration	NN	O	I-NP	B-Medical
119	4	over	IN	O	B-PP	O
119	5	surgical	JJ	O	B-NP	B-Medical
119	6	removal	NN	O	I-NP	O
119	7	of	IN	O	B-PP	O
119	8	his	PP$	O	B-NP	O
119	9	testicles	NNS	O	I-NP	O
119	10	.	.	O	O	O

120	0	``	``	O	O	O
120	1	At	IN	O	B-PP	O
120	2	least	JJS	O	O	O
120	3	there	EX	O	B-NP	O
120	4	is	VBZ	O	B-VP	O
120	5	a	DT	O	B-NP	O
120	6	hope	NN	O	I-NP	O
120	7	that	IN	O	O	O
120	8	if	IN	O	O	O
120	9	a	DT	O	B-NP	O
120	10	magic	NN	O	I-NP	O
120	11	bullet	NN	O	I-NP	O
120	12	is	VBZ	O	B-VP	O
120	13	found	VBN	O	I-VP	O
120	14	COMMA	COMMA	O	O	O
120	15	I	PRP	O	B-NP	O
120	16	can	MD	O	B-VP	O
120	17	go	VB	O	I-VP	O
120	18	back	RB	O	O	O
120	19	.	.	O	O	O

121	0	It	PRP	O	B-NP	O
121	1	's	VBZ	O	B-VP	O
121	2	reversible	JJ	O	O	O
121	3	.	.	O	O	O

122	0	That	DT	O	B-NP	O
122	1	's	VBZ	O	B-VP	O
122	2	a	DT	O	B-NP	O
122	3	big	JJ	O	I-NP	O
122	4	psychological	JJ	O	I-NP	B-Medical
122	5	differenceCOMMA	NN	O	I-NP	O
122	6	''	''	O	O	O
122	7	he	PRP	O	B-NP	O
122	8	said	VBD	O	B-VP	O
122	9	.	.	O	O	O

123	0	Ralph	NNP	O	B-NP	B-Peop
123	1	Valle	NNP	O	I-NP	I-Peop
123	2	COMMA	COMMA	O	O	O
123	3	of	IN	O	B-PP	O
123	4	Phoenix	NNP	O	B-NP	B-LocCit
123	5	COMMA	COMMA	O	O	O
123	6	Ariz.	NNP	O	B-NP	B-LocStat
123	7	COMMA	COMMA	O	O	O
123	8	opted	VBD	O	B-VP	O
123	9	for	IN	O	B-PP	O
123	10	surgical	JJ	O	B-NP	B-Medical
123	11	castration	NN	O	I-NP	B-Medical
123	12	COMMA	COMMA	O	O	O
123	13	known	VBN	O	B-VP	O
123	14	as	IN	O	B-PP	O
123	15	an	DT	O	B-NP	O
123	16	orchiectomy	NN	O	I-NP	O
123	17	COMMA	COMMA	O	O	O
123	18	after	IN	O	O	O
123	19	the	DT	O	B-NP	O
123	20	cancer	NN	O	I-NP	B-Medical
123	21	spread	NN	O	I-NP	O
123	22	.	.	O	O	O

124	0	Valle	NNP	O	B-NP	B-Peop
124	1	and	CC	O	O	O
124	2	his	PP$	O	B-NP	O
124	3	wife	NN	O	I-NP	O
124	4	were	VBD	O	B-VP	O
124	5	concerned	VBN	O	I-VP	O
124	6	that	DT	O	B-NP	O
124	7	chemical	NN	O	I-NP	B-Medical
124	8	castration	NN	O	I-NP	B-Medical
124	9	might	MD	O	B-VP	O
124	10	not	RB	O	I-VP	O
124	11	be	VB	O	I-VP	O
124	12	as	RB	O	O	O
124	13	effective	JJ	O	O	O
124	14	in	IN	O	B-PP	O
124	15	blocking	VBG	O	B-VP	O
124	16	hormone	NN	O	B-NP	B-Medical
124	17	production	NN	O	I-NP	O
124	18	.	.	O	O	O

125	0	``	``	O	O	O
125	1	I	PRP	O	B-NP	O
125	2	put	VBD	O	B-VP	O
125	3	everything	NN	O	B-NP	O
125	4	down	IN	O	O	O
125	5	on	IN	O	B-PP	O
125	6	paper	NN	O	B-NP	O
125	7	COMMA	COMMA	O	O	O
125	8	and	CC	O	O	O
125	9	I	PRP	O	B-NP	O
125	10	went	VBD	O	B-VP	O
125	11	through	IN	O	B-PP	O
125	12	a	DT	O	B-NP	O
125	13	decisionmaking	NN	O	I-NP	O
125	14	processCOMMA	NN	O	I-NP	O
125	15	''	''	O	O	O
125	16	said	VBD	O	B-VP	O
125	17	Valle	NNP	O	B-NP	B-Peop
125	18	COMMA	COMMA	O	O	O
125	19	a	DT	O	B-NP	O
125	20	manufacturing	NN	O	I-NP	O
125	21	executive	NN	O	I-NP	B-ProfTitle
125	22	who	WP	O	B-NP	O
125	23	was	VBD	O	B-VP	O
125	24	diagnosed	VBN	O	I-VP	O
125	25	six	CD	O	B-NP	B-Num
125	26	years	NNS	O	I-NP	B-Date
125	27	ago	IN	O	O	O
125	28	at	IN	O	B-PP	O
125	29	age	NN	O	B-NP	O
125	30	59	CD	O	I-NP	B-Num
125	31	.	.	O	O	O

126	0	``	``	O	O	O
126	1	I	PRP	O	B-NP	O
126	2	concluded	VBD	O	B-VP	O
126	3	that	IN	O	O	O
126	4	I	PRP	O	B-NP	O
126	5	am	VBP	O	B-VP	O
126	6	fighting	VBG	O	I-VP	B-Sport
126	7	for	IN	O	B-PP	O
126	8	my	PP$	O	B-NP	O
126	9	life	NN	O	I-NP	O
126	10	here	RB	O	O	O
126	11	.	.	O	O	O

127	0	`	``	O	O	O
127	1	Right	RB	O	O	O
127	2	or	CC	O	O	O
127	3	wrongCOMMA	NN	O	O	O
127	4	'	''	O	O	O
127	5	I	PRP	O	B-NP	B-Peop
127	6	said	VBD	O	B-VP	O
127	7	COMMA	COMMA	O	O	O
127	8	`	``	O	O	O
127	9	I	PRP	O	B-NP	O
127	10	'm	VBP	O	B-VP	O
127	11	going	VBG	O	I-VP	O
127	12	with	IN	O	B-PP	O
127	13	the	DT	O	B-NP	O
127	14	orchiectomy	NN	O	I-NP	O
127	15	.	.	O	O	O
127	16	'	''	O	O	O

128	0	It	PRP	O	B-NP	O
128	1	was	VBD	O	B-VP	O
128	2	very	RB	O	O	O
128	3	difficult	JJ	O	O	O
128	4	.	.	O	O	O
128	5	''	''	O	O	O

129	0	The	DT	O	B-NP	O
129	1	side	NN	O	I-NP	O
129	2	effects	NNS	O	I-NP	O
129	3	from	IN	O	B-PP	O
129	4	either	DT	O	B-NP	O
129	5	treatment	NN	O	I-NP	O
129	6	can	MD	O	B-VP	O
129	7	be	VB	O	I-VP	O
129	8	extreme	JJ	O	O	O
129	9	COMMA	COMMA	O	O	O
129	10	including	VBG	O	B-PP	O
129	11	total	JJ	O	B-NP	O
129	12	loss	NN	O	I-NP	O
129	13	of	IN	O	B-PP	O
129	14	sexual	JJ	O	B-NP	O
129	15	desire	NN	O	I-NP	O
129	16	COMMA	COMMA	O	O	O
129	17	facial	JJ	O	B-NP	B-Medical
129	18	hair	NN	O	I-NP	O
129	19	loss	NN	O	I-NP	O
129	20	COMMA	COMMA	O	O	O
129	21	weight	NN	O	B-NP	O
129	22	gain	NN	O	I-NP	O
129	23	COMMA	COMMA	O	O	O
129	24	emotional	JJ	O	B-NP	B-Medical
129	25	swings	NNS	O	I-NP	O
129	26	and	CC	O	O	O
129	27	hot	JJ	O	B-NP	O
129	28	flashes	NNS	O	I-NP	O
129	29	.	.	O	O	O

130	0	&	CC	O	O	O
130	1	UR	NNP	O	B-NP	O
130	2	;	:	O	O	O
130	3	-	:	O	O	O
130	4	-	:	O	O	O
130	5	-	:	O	O	O
130	6	&	CC	O	O	O
130	7	LR	NNP	O	B-NP	O
130	8	;	:	O	O	O
130	9	&	CC	O	O	O
130	10	QL	NNP	O	B-NP	O
130	11	;	:	O	O	O

131	0	&	CC	O	O	O
131	1	UR	NNP	O	B-NP	O
131	2	;	:	O	O	O
131	3	-	:	O	O	O
131	4	-	:	O	O	O
131	5	-	:	O	O	O
131	6	&	CC	O	O	O
131	7	LR	NNP	O	B-NP	O
131	8	;	:	O	O	O
131	9	&	CC	O	O	O
131	10	QL	NNP	O	B-NP	O
131	11	;	:	O	O	O

132	0	CRYOSURGERY	NNP	O	B-NP	O
132	1	:	:	O	O	O

133	0	While	IN	O	O	O
133	1	not	RB	O	O	O
133	2	yet	RB	O	O	O
133	3	in	IN	O	B-PP	O
133	4	widespread	JJ	O	B-NP	O
133	5	use	NN	O	I-NP	O
133	6	COMMA	COMMA	O	O	O
133	7	this	DT	O	B-NP	O
133	8	procedure	NN	O	I-NP	O
133	9	injects	VBZ	O	B-VP	O
133	10	liquid	JJ	O	B-NP	O
133	11	nitrogen	NN	O	I-NP	O
133	12	COMMA	COMMA	O	O	O
133	13	chilled	VBD	O	B-VP	O
133	14	to	TO	O	B-PP	O
133	15	temperatures	NNS	O	B-NP	O
133	16	minus-320	JJ	O	B-NP	O
133	17	degrees	NNS	O	I-NP	O
133	18	Fahrenheit	NNP	O	I-NP	O
133	19	COMMA	COMMA	O	O	O
133	20	into	IN	O	B-PP	O
133	21	the	DT	O	B-NP	O
133	22	prostate	NN	O	I-NP	B-Jour
133	23	to	TO	O	B-VP	O
133	24	freeze	VB	O	I-VP	O
133	25	cancer	NN	O	B-NP	B-Medical
133	26	cells	NNS	O	I-NP	O
133	27	.	.	O	O	O

134	0	Budson	NNP	O	B-NP	O
134	1	Ellsworth	NNP	O	I-NP	O
134	2	COMMA	COMMA	O	O	O
134	3	from	IN	O	B-PP	O
134	4	Downey	NNP	O	B-NP	B-Peop
134	5	COMMA	COMMA	O	O	O
134	6	Calif.	NNP	O	B-NP	B-LocStat
134	7	COMMA	COMMA	O	O	O
134	8	chose	VBD	O	B-VP	O
134	9	cryosurgery	NN	O	B-NP	O
134	10	over	IN	O	B-PP	O
134	11	other	JJ	O	B-NP	O
134	12	treatments	NNS	O	I-NP	O
134	13	after	IN	O	O	O
134	14	he	PRP	O	B-NP	O
134	15	was	VBD	O	B-VP	O
134	16	diagnosed	VBN	O	I-VP	O
134	17	in	IN	O	B-PP	O
134	18	1993	CD	O	B-NP	B-Date
134	19	at	IN	O	B-PP	O
134	20	age	VBP	O	B-NP	O
134	21	55	CD	O	I-NP	B-Num
134	22	with	IN	O	B-PP	O
134	23	extensive	JJ	O	B-NP	O
134	24	prostate	NN	O	I-NP	B-Jour
134	25	cancer	NN	O	I-NP	B-Medical
134	26	because	IN	O	O	O
134	27	he	PRP	O	B-NP	O
134	28	felt	VBD	O	B-VP	O
134	29	it	PRP	O	B-NP	O
134	30	offered	VBD	O	B-VP	O
134	31	more	RBR	O	B-NP	O
134	32	hope	NN	O	I-NP	O
134	33	and	CC	O	O	O
134	34	less	JJR	O	B-NP	O
134	35	risk	NN	O	I-NP	O
134	36	.	.	O	O	O

135	0	In	IN	O	B-PP	O
135	1	the	DT	O	B-NP	O
135	2	procedure	NN	O	I-NP	O
135	3	COMMA	COMMA	O	O	O
135	4	a	DT	O	B-NP	O
135	5	doctor	NN	O	I-NP	B-ProfTitle
135	6	was	VBD	O	B-VP	O
135	7	guided	VBN	O	I-VP	O
135	8	by	IN	O	B-PP	O
135	9	a	DT	O	B-NP	O
135	10	rectal	JJ	O	I-NP	B-Medical
135	11	ultrasound	NN	O	I-NP	O
135	12	probe	NN	O	I-NP	O
135	13	as	IN	O	O	O
135	14	he	PRP	O	B-NP	O
135	15	injected	VBD	O	B-VP	O
135	16	the	DT	O	B-NP	O
135	17	liquid	JJ	O	I-NP	O
135	18	nitrogen	NN	O	I-NP	O
135	19	through	IN	O	B-PP	O
135	20	the	DT	O	B-NP	O
135	21	perineum	NN	O	I-NP	O
135	22	COMMA	COMMA	O	O	O
135	23	turning	VBG	O	B-VP	O
135	24	Ellsworth	NNP	O	B-NP	B-Peop
135	25	's	POS	O	B-NP	O
135	26	prostate	NN	O	I-NP	B-Jour
135	27	into	IN	O	B-PP	O
135	28	an	DT	O	B-NP	O
135	29	ice	NN	O	I-NP	O
135	30	ball	NN	O	I-NP	O
135	31	.	.	O	O	O

136	0	Cryosurgery	NN	O	B-NP	O
136	1	is	VBZ	O	B-VP	O
136	2	much	RB	O	O	O
136	3	less	JJR	O	O	O
136	4	invasive	JJ	O	O	O
136	5	than	IN	O	B-PP	O
136	6	a	DT	O	B-NP	O
136	7	radical	JJ	O	I-NP	O
136	8	prostatectomy	NN	O	I-NP	O
136	9	COMMA	COMMA	O	O	O
136	10	but	CC	O	O	O
136	11	the	DT	O	B-NP	O
136	12	side	NN	O	I-NP	O
136	13	effects	NNS	O	I-NP	O
136	14	in	IN	O	B-PP	O
136	15	Ellsworth	NNP	O	B-NP	B-Loc
136	16	's	POS	O	B-NP	O
136	17	case	NN	O	I-NP	O
136	18	were	VBD	O	B-VP	O
136	19	just	RB	O	O	O
136	20	as	RB	O	O	O
136	21	severe	JJ	O	O	O
136	22	.	.	O	O	O

137	0	He	PRP	O	B-NP	O
137	1	ended	VBD	O	B-VP	O
137	2	up	IN	O	B-PP	O
137	3	impotent	JJ	O	B-NP	O
137	4	because	IN	O	O	O
137	5	the	DT	O	B-NP	O
137	6	entire	JJ	O	I-NP	O
137	7	gland	NN	O	I-NP	O
137	8	had	VBD	O	B-VP	O
137	9	to	TO	O	I-VP	O
137	10	be	VB	O	I-VP	O
137	11	frozen	VBN	O	I-VP	O
137	12	due	JJ	O	O	O
137	13	to	TO	O	B-PP	O
137	14	the	DT	O	B-NP	O
137	15	extent	NN	O	I-NP	O
137	16	of	IN	O	B-PP	O
137	17	the	DT	O	B-NP	O
137	18	cancer	NN	O	I-NP	B-Medical
137	19	.	.	O	O	O

138	0	Subsequently	RB	O	O	O
138	1	COMMA	COMMA	O	O	O
138	2	the	DT	O	B-NP	O
138	3	cancer	NN	O	I-NP	B-Medical
138	4	spread	NN	O	I-NP	O
138	5	to	TO	O	B-PP	O
138	6	his	PP$	O	B-NP	O
138	7	pelvic	JJ	O	I-NP	B-Medical
138	8	lymph	NN	O	I-NP	O
138	9	nodes	NNS	O	I-NP	O
138	10	and	CC	O	O	O
138	11	he	PRP	O	B-NP	O
138	12	began	VBD	O	B-VP	O
138	13	hormone	NN	O	B-NP	B-Medical
138	14	therapy	NN	O	I-NP	B-Medical
138	15	.	.	O	O	O

139	0	Doctors	NNS	O	B-NP	B-ProfTitle
139	1	say	VBP	O	B-VP	O
139	2	that	IN	O	O	O
139	3	in	IN	O	B-PP	O
139	4	cases	NNS	O	B-NP	O
139	5	where	WRB	O	O	O
139	6	the	DT	O	B-NP	O
139	7	tumors	NNS	O	I-NP	O
139	8	are	VBP	O	B-VP	O
139	9	small	JJ	O	O	O
139	10	COMMA	COMMA	O	O	O
139	11	the	DT	O	B-NP	O
139	12	procedure	NN	O	I-NP	O
139	13	produces	VBZ	O	B-VP	O
139	14	minimal	JJ	O	B-NP	O
139	15	side	NN	O	I-NP	O
139	16	effects	NNS	O	I-NP	O
139	17	.	.	O	O	O

140	0	While	IN	O	O	O
140	1	there	EX	O	B-NP	O
140	2	is	VBZ	O	B-VP	O
140	3	a	DT	O	B-NP	O
140	4	limit	NN	O	I-NP	O
140	5	to	TO	O	B-PP	O
140	6	the	DT	O	B-NP	O
140	7	amount	NN	O	I-NP	O
140	8	of	IN	O	B-PP	O
140	9	radiation	NN	O	B-NP	O
140	10	a	DT	O	B-NP	O
140	11	person	NN	O	I-NP	O
140	12	can	MD	O	B-VP	O
140	13	withstand	VB	O	I-VP	O
140	14	COMMA	COMMA	O	O	O
140	15	cryosurgery	NN	O	B-NP	O
140	16	patients	NNS	O	I-NP	O
140	17	can	MD	O	B-VP	O
140	18	be	VB	O	I-VP	O
140	19	re-treated	JJ	O	O	O
140	20	if	IN	O	O	O
140	21	necessary	JJ	O	O	O
140	22	.	.	O	O	O

141	0	&	CC	O	O	O
141	1	UR	NNP	O	B-NP	O
141	2	;	:	O	O	O
141	3	-	:	O	O	O
141	4	-	:	O	O	O
141	5	-	:	O	O	O
141	6	&	CC	O	O	O
141	7	LR	NNP	O	B-NP	O
141	8	;	:	O	O	O
141	9	&	CC	O	O	O
141	10	QL	NNP	O	B-NP	O
141	11	;	:	O	O	O

142	0	&	CC	O	O	O
142	1	UR	NNP	O	B-NP	O
142	2	;	:	O	O	O
142	3	-	:	O	O	O
142	4	-	:	O	O	O
142	5	-	:	O	O	O
142	6	&	CC	O	O	O
142	7	LR	NNP	O	B-NP	O
142	8	;	:	O	O	O
142	9	&	CC	O	O	O
142	10	QL	NNP	O	B-NP	O
142	11	;	:	O	O	O

143	0	CHEMOTHERAPY	NNP	O	B-NP	B-Jour
143	1	:	:	O	O	O

144	0	Until	IN	O	B-PP	O
144	1	recently	RB	O	O	O
144	2	COMMA	COMMA	O	O	O
144	3	chemical	NN	O	B-NP	B-Medical
144	4	toxins	NNS	O	I-NP	O
144	5	were	VBD	O	B-VP	O
144	6	the	DT	O	B-NP	O
144	7	last-resort	JJ	O	I-NP	O
144	8	defense	NN	O	I-NP	O
144	9	against	IN	O	B-PP	O
144	10	prostate	NN	O	B-NP	B-Jour
144	11	cancer	NN	O	I-NP	B-Medical
144	12	because	IN	O	O	O
144	13	chemotherapy	NN	O	B-NP	B-Jour
144	14	had	VBD	O	B-VP	O
144	15	little	JJ	O	B-NP	O
144	16	effect	NN	O	I-NP	O
144	17	shrinking	VBG	O	I-NP	O
144	18	tumors	NNS	O	I-NP	O
144	19	or	CC	O	O	O
144	20	extending	VBG	O	B-VP	O
144	21	life	NN	O	B-NP	O
144	22	.	.	O	O	O

145	0	Doctors	NNS	O	B-NP	B-ProfTitle
145	1	now	RB	O	O	O
145	2	are	VBP	O	B-VP	O
145	3	having	VBG	O	I-VP	O
145	4	better	JJR	O	B-NP	O
145	5	results	NNS	O	I-NP	O
145	6	using	VBG	O	B-VP	O
145	7	chemotherapy	NN	O	B-NP	B-Jour
145	8	in	IN	O	B-PP	O
145	9	new	JJ	O	B-NP	O
145	10	combinations	NNS	O	I-NP	O
145	11	COMMA	COMMA	O	O	O
145	12	with	IN	O	O	O
145	13	hormone	NN	O	B-NP	B-Medical
145	14	blocking	VBG	O	O	O
145	15	drugs	NNS	O	B-NP	O
145	16	and	CC	O	B-PP	O
145	17	with	IN	O	B-PP	O
145	18	other	JJ	O	B-NP	O
145	19	compounds	NNS	O	I-NP	O
145	20	when	WRB	O	O	O
145	21	other	JJ	O	B-NP	O
145	22	treatments	NNS	O	I-NP	O
145	23	fail	VBP	O	B-VP	O
145	24	.	.	O	O	O

146	0	``	``	O	O	O
146	1	A	DT	O	B-NP	O
146	2	few	JJ	O	I-NP	O
146	3	years	NNS	O	I-NP	B-Date
146	4	ago	IN	O	O	O
146	5	COMMA	COMMA	O	O	O
146	6	for	IN	O	B-PP	O
146	7	a	DT	O	B-NP	O
146	8	patient	NN	O	I-NP	B-Medical
146	9	with	IN	O	B-PP	O
146	10	advanced	VBN	O	B-NP	O
146	11	disease	NN	O	I-NP	B-Medical
146	12	COMMA	COMMA	O	O	O
146	13	they	PRP	O	B-NP	O
146	14	'd	MD	O	B-VP	O
146	15	give	VB	O	I-VP	O
146	16	him	PRP	O	B-NP	O
146	17	hormonal	JJ	O	B-NP	B-Medical
146	18	treatments	NNS	O	I-NP	O
146	19	and	CC	O	O	O
146	20	then	RB	O	O	O
146	21	he	PRP	O	B-NP	O
146	22	'd	MD	O	B-VP	O
146	23	die	VB	O	I-VP	O
146	24	.	.	O	O	O

147	0	Now	RB	O	O	O
147	1	there	EX	O	B-NP	O
147	2	are	VBP	O	B-VP	O
147	3	numerous	JJ	O	B-NP	O
147	4	strategiesCOMMA	NN	O	I-NP	O
147	5	''	''	O	O	O
147	6	said	VBD	O	B-VP	O
147	7	Dr.	NNP	O	B-NP	B-ProfTitle
147	8	Kenneth	NNP	O	I-NP	B-Peop
147	9	Pienta	NNP	O	I-NP	I-Peop
147	10	COMMA	COMMA	O	O	O
147	11	director	NN	O	B-NP	B-ProfTitle
147	12	of	IN	O	B-PP	O
147	13	genito-urinary	JJ	O	B-NP	O
147	14	oncology	NN	O	I-NP	B-Jour
147	15	at	IN	O	B-PP	O
147	16	the	DT	O	B-NP	O
147	17	University	NNP	O	I-NP	B-OrgUniv
147	18	of	IN	O	B-PP	I-OrgUniv
147	19	Michigan	NNP	O	B-NP	I-OrgUniv
147	20	.	.	O	O	O

148	0	In	IN	O	B-PP	O
148	1	one	CD	O	B-NP	B-Num
148	2	such	JJ	O	I-NP	O
148	3	strategy	NN	O	I-NP	O
148	4	COMMA	COMMA	O	O	O
148	5	four	CD	O	B-NP	B-Num
148	6	drugs	NNS	O	I-NP	O
148	7	_	NN	O	I-NP	O
148	8	Adriamycin	NNP	O	I-NP	O
148	9	COMMA	COMMA	O	O	O
148	10	Ketoconazole	NNP	O	O	B-Loc
148	11	COMMA	COMMA	O	O	O
148	12	Vinblastine	NNP	O	B-NP	B-Loc
148	13	COMMA	COMMA	O	O	O
148	14	and	CC	O	O	O
148	15	Estramustine	NNP	O	B-NP	O
148	16	_	NN	O	I-NP	O
148	17	are	VBP	O	B-VP	O
148	18	administered	VBN	O	I-VP	O
148	19	during	IN	O	B-PP	O
148	20	a	DT	O	B-NP	O
148	21	two-month	JJ	O	I-NP	O
148	22	period	NN	O	I-NP	O
148	23	.	.	O	O	O

149	0	Compared	VBN	O	B-PP	O
149	1	with	IN	O	B-PP	O
149	2	traditional	JJ	O	B-NP	O
149	3	chemo	NN	O	I-NP	O
149	4	COMMA	COMMA	O	O	O
149	5	the	DT	O	B-NP	O
149	6	combinations	NNS	O	I-NP	O
149	7	are	VBP	O	B-VP	O
149	8	better	RBR	O	O	O
149	9	able	JJ	O	O	O
149	10	to	TO	O	B-VP	O
149	11	target	VB	O	I-VP	O
149	12	and	CC	O	O	O
149	13	kill	VBP	O	B-VP	O
149	14	prostate	NN	O	B-NP	B-Jour
149	15	cancer	NN	O	I-NP	B-Medical
149	16	cells	NNS	O	I-NP	O
149	17	while	IN	O	O	O
149	18	minimizing	VBG	O	B-VP	O
149	19	damage	NN	O	B-NP	O
149	20	to	TO	O	B-PP	O
149	21	healthy	JJ	O	B-NP	O
149	22	cells	NNS	O	I-NP	O
149	23	.	.	O	O	O

150	0	Pienta	NNP	O	B-NP	B-Peop
150	1	says	VBZ	O	B-VP	O
150	2	some	DT	O	B-NP	O
150	3	patients	NNS	O	I-NP	O
150	4	survive	VBP	O	B-VP	O
150	5	up	IN	O	O	O
150	6	to	TO	O	O	O
150	7	two	CD	O	B-NP	B-Num
150	8	years	NNS	O	I-NP	B-Date
150	9	on	IN	O	B-PP	O
150	10	the	DT	O	B-NP	O
150	11	combined	VBN	O	I-NP	O
150	12	chemotherapies	NNS	O	I-NP	O
150	13	.	.	O	O	O

151	0	``	``	O	O	O
151	1	The	DT	O	B-NP	O
151	2	potential	NN	O	I-NP	O
151	3	for	IN	O	B-PP	O
151	4	the	DT	O	B-NP	O
151	5	prostate	NN	O	I-NP	B-Jour
151	6	cancer	NN	O	I-NP	B-Medical
151	7	death	NN	O	I-NP	O
151	8	rate	NN	O	I-NP	O
151	9	to	TO	O	B-VP	O
151	10	go	VB	O	I-VP	O
151	11	down	IN	O	O	O
151	12	a	DT	O	B-NP	O
151	13	lot	NN	O	I-NP	O
151	14	over	IN	O	B-PP	O
151	15	the	DT	O	B-NP	O
151	16	next	JJ	O	I-NP	O
151	17	five	CD	O	I-NP	B-Num
151	18	years	NNS	O	I-NP	B-Date
151	19	is	VBZ	O	B-VP	O
151	20	quite	RB	O	O	O
151	21	highCOMMA	NN	O	O	O
151	22	''	''	O	O	O
151	23	he	PRP	O	B-NP	O
151	24	said	VBD	O	B-VP	O
151	25	.	.	O	O	O

152	0	Researchers	NNS	O	B-NP	B-ProfTitle
152	1	also	RB	O	O	O
152	2	are	VBP	O	B-VP	O
152	3	examining	VBG	O	I-VP	O
152	4	the	DT	O	B-NP	O
152	5	use	NN	O	I-NP	O
152	6	of	IN	O	B-PP	O
152	7	new	JJ	O	B-NP	O
152	8	chemotherapy	NN	O	I-NP	B-Jour
152	9	combinations	NNS	O	I-NP	O
152	10	as	IN	O	B-PP	O
152	11	a	DT	O	B-NP	O
152	12	frontline	NN	O	I-NP	O
152	13	treatment	NN	O	I-NP	O
152	14	for	IN	O	B-PP	O
152	15	early-stage	JJ	O	B-NP	O
152	16	prostate	NN	O	I-NP	B-Jour
152	17	cancer	NN	O	I-NP	B-Medical
152	18	.	.	O	O	O

153	0	While	IN	O	O	O
153	1	researchers	NNS	O	B-NP	B-ProfTitle
153	2	are	VBP	O	B-VP	O
153	3	trying	VBG	O	I-VP	O
153	4	to	TO	O	I-VP	O
153	5	make	VB	O	I-VP	O
153	6	the	DT	O	B-NP	O
153	7	drugs	NNS	O	I-NP	O
153	8	more	RBR	O	O	O
153	9	tolerable	JJ	O	O	O
153	10	COMMA	COMMA	O	O	O
153	11	the	DT	O	B-NP	O
153	12	side	NN	O	I-NP	O
153	13	effects	NNS	O	I-NP	O
153	14	can	MD	O	B-VP	O
153	15	be	VB	O	I-VP	O
153	16	severe	JJ	O	O	O
153	17	COMMA	COMMA	O	O	O
153	18	including	VBG	O	B-PP	O
153	19	hair	NN	O	B-NP	O
153	20	loss	NN	O	I-NP	O
153	21	COMMA	COMMA	O	O	O
153	22	vomiting	NN	O	B-NP	B-Medical
153	23	and	CC	O	O	O
153	24	lowered	VBD	O	B-VP	O
153	25	blood	NN	O	B-NP	O
153	26	counts	NNS	O	I-NP	O
153	27	that	IN	O	B-NP	O
153	28	make	VBP	O	B-VP	O
153	29	the	DT	O	B-NP	O
153	30	body	NN	O	I-NP	O
153	31	vulnerable	JJ	O	O	O
153	32	to	TO	O	B-PP	O
153	33	infection	NN	O	B-NP	B-Medical
153	34	.	.	O	O	O

154	0	&	CC	O	O	O
154	1	UR	NNP	O	B-NP	O
154	2	;	:	O	O	O
154	3	-	:	O	O	O
154	4	-	:	O	O	O
154	5	-	:	O	O	O
154	6	&	CC	O	O	O
154	7	LR	NNP	O	B-NP	O
154	8	;	:	O	O	O
154	9	&	CC	O	O	O
154	10	QL	NNP	O	B-NP	O
154	11	;	:	O	O	O

155	0	&	CC	O	O	O
155	1	UR	NNP	O	B-NP	O
155	2	;	:	O	O	O
155	3	-	:	O	O	O
155	4	-	:	O	O	O
155	5	-	:	O	O	O
155	6	&	CC	O	O	O
155	7	LR	NNP	O	B-NP	O
155	8	;	:	O	O	O
155	9	&	CC	O	O	O
155	10	QL	NNP	O	B-NP	O
155	11	;	:	O	O	O

156	0	WATCHFUL	NNP	O	B-NP	O
156	1	WAITING	NNP	O	I-NP	O
156	2	:	:	O	O	O

157	0	Because	IN	O	O	O
157	1	prostate	NN	O	B-NP	B-Jour
157	2	cancer	NN	O	I-NP	B-Medical
157	3	is	VBZ	O	B-VP	O
157	4	often	RB	O	O	O
157	5	slow-growing	JJ	O	O	O
157	6	COMMA	COMMA	O	O	O
157	7	some	DT	O	B-NP	O
157	8	physicians	NNS	O	I-NP	B-ProfTitle
157	9	may	MD	O	B-VP	O
157	10	advise	VB	O	I-VP	O
157	11	elderly	JJ	O	B-NP	O
157	12	men	NNS	O	I-NP	O
157	13	or	CC	O	O	O
157	14	those	DT	O	B-NP	O
157	15	with	IN	O	B-PP	O
157	16	a	DT	O	B-NP	O
157	17	life	NN	O	I-NP	O
157	18	expectancy	NN	O	I-NP	O
157	19	of	IN	O	B-PP	O
157	20	less	JJR	O	B-NP	O
157	21	than	IN	O	I-NP	O
157	22	10	CD	O	I-NP	B-Num
157	23	years	NNS	O	I-NP	I-Num
157	24	due	JJ	O	O	O
157	25	to	TO	O	B-PP	O
157	26	other	JJ	O	B-NP	O
157	27	illnesses	NNS	O	I-NP	O
157	28	to	TO	O	B-VP	O
157	29	do	VB	O	I-VP	O
157	30	nothing	NN	O	B-NP	O
157	31	.	.	O	O	O

158	0	The	DT	O	B-NP	O
158	1	assumption	NN	O	I-NP	O
158	2	here	RB	O	O	O
158	3	is	VBZ	O	B-VP	O
158	4	that	IN	O	O	O
158	5	the	DT	O	B-NP	O
158	6	patient	NN	O	I-NP	B-Medical
158	7	won	VBD	O	B-VP	O
158	8	't	NN	O	B-NP	O
158	9	be	VB	O	B-VP	O
158	10	cured	VBN	O	I-VP	O
158	11	of	IN	O	B-PP	O
158	12	the	DT	O	B-NP	O
158	13	disease	NN	O	I-NP	B-Medical
158	14	and	CC	O	O	O
158	15	will	MD	O	B-VP	O
158	16	likely	RB	O	I-VP	O
158	17	die	NN	O	I-VP	O
158	18	with	IN	O	B-PP	O
158	19	it	PRP	O	B-NP	O
158	20	rather	RB	O	O	O
158	21	than	IN	O	O	O
158	22	from	IN	O	B-PP	O
158	23	it	PRP	O	B-NP	O
158	24	.	.	O	O	O

159	0	Under	IN	O	B-PP	O
159	1	the	DT	O	B-NP	O
159	2	``	``	O	I-NP	O
159	3	watchful	JJ	O	I-NP	O
159	4	waiting	NN	O	I-NP	O
159	5	''	''	O	I-NP	O
159	6	approach	NN	O	I-NP	O
159	7	COMMA	COMMA	O	O	O
159	8	the	DT	O	B-NP	O
159	9	physician	NN	O	I-NP	B-ProfTitle
159	10	may	MD	O	B-VP	O
159	11	recommend	VB	O	I-VP	O
159	12	non-curative	JJ	O	B-NP	O
159	13	treatment	NN	O	I-NP	O
159	14	.	.	O	O	O

160	0	``	``	O	O	O
160	1	I	PRP	O	B-NP	O
160	2	say	VBP	O	B-VP	O
160	3	to	TO	O	B-PP	O
160	4	these	DT	O	B-NP	O
160	5	men	NNS	O	I-NP	O
160	6	COMMA	COMMA	O	O	O
160	7	usually	RB	O	O	O
160	8	in	IN	O	O	O
160	9	their	PP$	O	B-NP	O
160	10	upper	JJ	O	I-NP	O
160	11	70s	NN	O	I-NP	B-Num
160	12	COMMA	COMMA	O	O	O
160	13	`	``	O	O	O
160	14	Look	NNP	O	B-NP	O
160	15	COMMA	COMMA	O	O	O
160	16	you	PRP	O	B-NP	O
160	17	've	VBP	O	B-VP	O
160	18	got	VBN	O	I-VP	O
160	19	prostate	NN	O	B-NP	B-Jour
160	20	cancer	NN	O	I-NP	B-Medical
160	21	.	.	O	O	O

161	0	But	CC	O	O	O
161	1	it	PRP	O	B-NP	O
161	2	's	VBZ	O	B-VP	O
161	3	not	RB	O	O	O
161	4	time	NN	O	B-NP	O
161	5	yet	RB	O	O	O
161	6	to	TO	O	B-VP	O
161	7	pull	VB	O	I-VP	O
161	8	the	DT	O	B-NP	O
161	9	trigger	NN	O	I-NP	O
161	10	.	.	O	O	O

162	0	Why	WRB	O	O	O
162	1	bother	VBP	O	B-VP	O
162	2	with	IN	O	B-PP	O
162	3	the	DT	O	B-NP	O
162	4	side	NN	O	I-NP	O
162	5	effects	NNS	O	I-NP	O
162	6	of	IN	O	B-PP	O
162	7	treatments	NNS	O	B-NP	O
162	8	?	.	O	O	O
162	9	''	''	O	O	O
162	10	'	''	O	O	O
162	11	said	VBD	O	B-VP	O
162	12	Shipley	NNP	O	B-NP	B-OrgCorp
162	13	.	.	O	O	O

163	0	Watchful	JJ	O	O	O
163	1	waiting	VBG	O	B-NP	O
163	2	is	VBZ	O	B-VP	O
163	3	not	RB	O	O	O
163	4	advisable	JJ	O	O	O
163	5	for	IN	O	B-PP	O
163	6	men	NNS	O	B-NP	O
163	7	under	IN	O	B-PP	O
163	8	65	CD	O	B-NP	B-Num
163	9	with	IN	O	B-PP	O
163	10	non-aggressive	JJ	O	B-NP	O
163	11	tumors	NNS	O	I-NP	O
163	12	that	WDT	O	B-NP	O
163	13	are	VBP	O	B-VP	O
163	14	potentially	RB	O	O	O
163	15	curable	JJ	O	O	O
163	16	.	.	O	O	O

164	0	Jan	NNP	O	B-NP	B-Peop
164	1	Marfyaic	NNP	O	I-NP	I-Peop
164	2	chose	VBD	O	B-VP	O
164	3	to	TO	O	I-VP	O
164	4	wait	VB	O	I-VP	O
164	5	two	CD	O	B-NP	B-Num
164	6	and	CC	O	O	O
164	7	one-half	JJ	O	B-NP	O
164	8	years	NNS	O	I-NP	B-Date
164	9	after	IN	O	B-PP	O
164	10	being	VBG	O	B-VP	O
164	11	diagnosed	VBN	O	I-VP	O
164	12	with	IN	O	B-PP	O
164	13	early-stage	JJ	O	B-NP	O
164	14	prostate	NN	O	I-NP	B-Jour
164	15	cancer	NN	O	I-NP	B-Medical
164	16	.	.	O	O	O

165	0	He	PRP	O	B-NP	O
165	1	then	RB	O	O	O
165	2	settled	VBD	O	B-VP	O
165	3	on	IN	O	B-PP	O
165	4	radioactive	JJ	O	B-NP	O
165	5	seed	NN	O	I-NP	O
165	6	therapy	NN	O	I-NP	B-Medical
165	7	.	.	O	O	O

166	0	``	``	O	O	O
166	1	It	PRP	O	B-NP	O
166	2	was	VBD	O	B-VP	O
166	3	slow	JJ	O	O	O
166	4	growing	VBG	O	O	O
166	5	and	CC	O	O	O
166	6	I	PRP	O	B-NP	O
166	7	figured	VBD	O	B-VP	O
166	8	I	PRP	O	B-NP	O
166	9	had	VBD	O	B-VP	O
166	10	time	NN	O	B-NP	O
166	11	to	TO	O	B-VP	O
166	12	make	VB	O	I-VP	O
166	13	a	DT	O	B-NP	O
166	14	decision	NN	O	I-NP	O
166	15	''	''	O	O	O
166	16	he	PRP	O	B-NP	O
166	17	said	VBD	O	B-VP	O
166	18	.	.	O	O	O

167	0	But	CC	O	O	O
167	1	Garnick	NNP	O	B-NP	B-Peop
167	2	believes	VBZ	O	B-VP	O
167	3	watchful	JJ	O	B-NP	O
167	4	waiting	NN	O	I-NP	O
167	5	is	VBZ	O	B-VP	O
167	6	risky	JJ	O	O	O
167	7	for	IN	O	O	O
167	8	men	NNS	O	B-NP	O
167	9	like	VBP	O	B-VP	O
167	10	Marfyaic	NNP	O	B-NP	O
167	11	.	.	O	O	O

168	0	``	``	O	O	O
168	1	We	PRP	O	B-NP	O
168	2	believe	VBP	O	B-VP	O
168	3	that	IN	O	O	O
168	4	such	JJ	O	B-NP	O
168	5	patients	NNS	O	I-NP	O
168	6	should	MD	O	B-VP	O
168	7	be	VB	O	I-VP	O
168	8	treated	VBN	O	I-VP	O
168	9	with	IN	O	B-PP	O
168	10	curative	JJ	O	B-NP	B-Medical
168	11	intent	NN	O	I-NP	O
168	12	rather	RB	O	O	O
168	13	than	IN	O	O	O
168	14	observed	VBN	O	B-VP	O
168	15	.	.	O	O	O

169	0	The	DT	O	B-NP	O
169	1	latter	JJ	O	I-NP	O
169	2	practice	NN	O	I-NP	O
169	3	potentially	RB	O	O	O
169	4	allows	VBZ	O	B-VP	O
169	5	the	DT	O	B-NP	O
169	6	cancer	NN	O	I-NP	B-Medical
169	7	to	TO	O	B-VP	O
169	8	grow	VB	O	I-VP	O
169	9	COMMA	COMMA	O	O	O
169	10	metastasize	VB	O	O	O
169	11	and	CC	O	O	O
169	12	become	VBP	O	B-VP	O
169	13	incurableCOMMA	NN	O	B-NP	O
169	14	''	''	O	O	O
169	15	Garnick	NNP	O	B-NP	B-Peop
169	16	said	VBD	O	B-VP	O
169	17	.	.	O	O	O
